var title_f21_20_21824="Dobutamine echo mortality-I";
var content_f21_20_21824=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F64154%7ECARD%2F75910&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F64154%7ECARD%2F75910&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Extent of abnormality on dobutamine echocardiography predicts outcome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 365px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In a study of 3156 patients undergoing dobutamine echocardiography, survival in patients with a normal test was significantly different from those with functional abnormalities of increasing severity, ie, number of abnormal territories.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Marwick, TH, Case, C, Sawada, S, J Am Coll Cardiol 2001; 37:754.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 497px\">",
"   <div class=\"ttl\">",
"    Dobutamine echocardiography predicts cardiac mortality",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 477px; height: 437px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In a study of 3156 patients, those with an abnormal dobutamine echocardiogram (ischemic, scar, or mixed) have a higher cardiac mortality compared to those with a normal echocardiogram. The highest mortality is in those with both scar and ischemia (mixed). Kaplan-Meier survival curves for the prediction of cardiac mortality based on results of dobutamine echocardiography.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Marwick, TH, Case, C, Sawada, S, J Am Coll Cardiol 2001; 37:754.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_20_21824=[""].join("\n");
var outline_f21_20_21824=null;
var title_f21_20_21825="RF energy delivery";
var content_f21_20_21825=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F81200&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F81200&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    The \"Stretta\" procedure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 365px; height: 282px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Diagram showing the balloon inflation, deployment of needles, RF energy delivery, and irrigation of the mucosa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of George Triadafilopoulos, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_20_21825=[""].join("\n");
var outline_f21_20_21825=null;
var title_f21_20_21826="Enterotomy for metastatic CA";
var content_f21_20_21826=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F68932&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F68932&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Enterotomies",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 354px; height: 503px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_20_21826=[""].join("\n");
var outline_f21_20_21826=null;
var title_f21_20_21827="EGFR inhbtr acneiform erupt";
var content_f21_20_21827=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F55753&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F55753&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acneiform eruption secondary to epidermal growth factor receptor (EGFR) inhibitor therapy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 491px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Diffuse erythematous follicular papules on the back of this patient treated with gefitinib.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Aimee S. Payne, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_20_21827=[""].join("\n");
var outline_f21_20_21827=null;
var title_f21_20_21828="Scleroderma lung disease PA";
var content_f21_20_21828=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F51163&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F51163&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Scleroderma lung disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 368px; height: 286px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest x-ray of a patient with scleroderma and interstitial lung disease. Note the bilateral basal reticulonodular shadowing.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_20_21828=[""].join("\n");
var outline_f21_20_21828=null;
var title_f21_20_21829="Ultrasound of second extensor compartment wrist";
var content_f21_20_21829=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F85862&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F85862&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 632px\">",
"   <div class=\"ttl\">",
"    Ultrasound of the second extensor compartment of the wrist",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 612px; height: 347px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    These ultrasound images show the second extensor compartment of the wrist. The superior image, marked by the red box, was obtained with the ultrasound probed positioned at the site of the red mark in the photograph. The image below was obtained with the probe at the yellow mark.",
"    <div class=\"footnotes\">",
"     APL: abductor pollicis longus; ECRL: extensor carpi radialis longus; ECRB: extensor carpi radialis brevis; EPB: extensor pollicis brevis.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Blake Boggess, DO.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_20_21829=[""].join("\n");
var outline_f21_20_21829=null;
var title_f21_20_21830="Insulin-induced hypoglycemia test";
var content_f21_20_21830=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Insulin-induced hypoglycemia test",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/20/21830/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/20/21830/contributors\">",
"     Lynnette K Nieman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/20/21830/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/20/21830/contributors\">",
"     Andre Lacroix, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/20/21830/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/20/21830/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/20/21830/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of adrenal insufficiency can be made by the finding of low morning serum cortisol concentration and low 24-hour urinary cortisol excretion, often with a subnormal response to corticotropin (ACTH). In some circumstances, however, other tests, such as insulin-induced hypoglycemia, are utilized to evaluate the response to stress, particularly when ACTH deficiency is suspected as the cause. This stress test also is used to establish a diagnosis of growth hormone deficiency. It has been used in patients with suspected Cushing's syndrome, but is not recommended as a diagnostic test in this setting.",
"   </p>",
"   <p>",
"    Details of the insulin-induced hypoglycemia test in adults will be reviewed here. Additional information on the diagnoses of adrenal insufficiency, growth hormone deficiency, and Cushing&rsquo;s syndrome in adults is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/46/44777?source=see_link\">",
"     \"Diagnosis of adrenal insufficiency in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/50/1833?source=see_link\">",
"     \"Growth hormone deficiency in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21913?source=see_link\">",
"     \"Establishing the diagnosis of Cushing's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INSULIN-INDUCED HYPOGLYCEMIA TEST",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1824008\">",
"    <span class=\"h2\">",
"     Stress response",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stress is difficult to define, let alone to reproduce. However, hypoglycemia causes a major stress response, with increases in plasma ACTH and serum cortisol, growth hormone, and prolactin, and activation of the sympathetic nervous system. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29638?source=see_link\">",
"     \"Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1824015\">",
"    <span class=\"h2\">",
"     Advantages/disadvantages",
"    </span>",
"    &nbsp;&mdash;&nbsp;As a stress test, insulin-induced hypoglycemia has certain advantages:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      This test evaluates the integrity of the full hypothalamic-pituitary-adrenal axis as hypoglycemia acts centrally to stimulate hypothalamic corticotropin-releasing hormone (CRH) release and, therefore, ACTH release",
"     </li>",
"     <li>",
"      The degree of hypoglycemia can easily be quantified",
"     </li>",
"     <li>",
"      The test is safe, if a clinician is present, in patients with no history of seizures or cardiovascular or cerebrovascular disease",
"     </li>",
"     <li>",
"      The hypoglycemia can be corrected within seconds by intravenous infusion of glucose",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, compared with other tests for the diagnosis of adrenal insufficiency, it is more difficult to perform, has some risk, and is more expensive. As a result, it is rarely performed in clinical practice for the assessment of pituitary-adrenal function.",
"   </p>",
"   <p>",
"    The magnitude of the response depends upon the degree of hypoglycemia. Criteria (ie, rate and degree of fall in serum glucose) that are adequate to elicit a maximal serum growth hormone response are inadequate to ensure a maximal plasma ACTH response. Thus, since the purpose of the test is to increase ACTH release, more stringent criteria of adequate hypoglycemia must be applied.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H727077\">",
"    <span class=\"h2\">",
"     Suggested use",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although insulin-induced hypoglycemia is a valid and perhaps the most rational test of hypothalamic-pituitary-adrenal response to stress, in most settings the one-hour ACTH stimulation test provides nearly the same information, is less difficult and expensive to perform, and is without risk to the patient. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/20/24905?source=see_link\">",
"     \"Evaluation of the response to ACTH in adrenal insufficiency\"",
"    </a>",
"    .) Pituitary surgery is the main clinical scenario when the ACTH stimulation test may not be as useful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H621972649\">",
"    <span class=\"h3\">",
"     After pituitary surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;If ACTH deficiency occurs as a result of transsphenoidal surgery, the cortisol response to exogenous ACTH stimulation may by normal until the adrenal glands atrophy. In this setting, insulin-induced hypoglycemia may be a better test to diagnose ACTH deficiency because the ACTH response to hypoglycemia may be lost [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/1\">",
"     1",
"    </a>",
"    ]. This is suggested by the discrepancy in responses to both the 250 and 1 mcg ACTH stimulation test compared with insulin hypoglycemia. In one study of 19 patients after transsphenoidal surgery, 6 of 19 patients had an abnormal response to insulin within 11 days of surgery, but two of these had normal responses to the 1 mcg and five had normal response to the 250 mcg ACTH stimulation test [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/1\">",
"     1",
"    </a>",
"    ]. In another study, at three to five weeks after surgery, six patients with an abnormal cortisol response to the 1 mcg ACTH stimulation test had normal responses to insulin, while three with normal responses to the 250 mcg test had an abnormal response to insulin [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/2\">",
"     2",
"    </a>",
"    ]. A third study showed that 23 of 62 patients with initial normal responses to 250 mcg ACTH had an abnormal response when tested at one or three months. Based on this, it appears that ACTH stimulation tests are not an appropriate test for adrenal insufficiency in the immediate post-operative period, and that at one month after surgery the 250 mcg test may under-diagnose while the 1 mcg test may over-diagnose adrenal insufficiency.",
"   </p>",
"   <p>",
"    However, an abnormal cortisol response to insulin-induced hypoglycemia test in the immediate post-operative period may not predict long-term dysfunction. In one study of 36 patients with an abnormal response to insulin at three months after surgery, 20 patients had a normal response at 12 months [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/3\">",
"     3",
"    </a>",
"    ]. In another, all six patients with an abnormal response to insulin in the immediate postoperative period had a normal response at three months [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/1\">",
"     1",
"    </a>",
"    ]. By contrast, very few patients with an initially normal response to insulin or ACTH progress to an abnormal function [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The basal cortisol level after surgery may be a useful indicator of adrenal function. A morning value &gt;250 to 300",
"    <span class=\"nowrap\">",
"     nmol/L",
"    </span>",
"    (9 to 11",
"    <span class=\"nowrap\">",
"     mcg/dL)",
"    </span>",
"    within eight days of surgery predicts a normal response to insulin [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/2,6-8\">",
"     2,6-8",
"    </a>",
"    ]. Conversely, basal values of 80 to 111",
"    <span class=\"nowrap\">",
"     nmol/L",
"    </span>",
"    (3 to 4",
"    <span class=\"nowrap\">",
"     mcg/dL)",
"    </span>",
"    predict an abnormal response. Intermediate values may represent normal or abnormal function.",
"   </p>",
"   <p>",
"    The preoperative assessment of adrenal function is also helpful, as patients with abnormal function are unlikely to regain function and should receive perioperative glucocorticoid coverage and post-operative replacement therapy. Patients with normal adrenal function before surgery should receive post-operative assessment. We suggest that patients receive perioperative glucocorticoid treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    to avoid suppression of the hypothalamic-pituitary-adrenal axis. Because the basal morning serum cortisol can provide very useful information, we suggest that it be measured within eight days of surgery, before any glucocorticoid is administered. Values greater than 250 to 300",
"    <span class=\"nowrap\">",
"     nmol/L",
"    </span>",
"    suggest that the patient does not require glucocorticoid replacement, while indeterminate values or those less than 111",
"    <span class=\"nowrap\">",
"     nmol/L",
"    </span>",
"    suggest that glucocorticoid replacement is prudent until further testing is performed. More definitive testing at three months using ACTH or hypoglycemia to stimulate the axis is needed in these patients. Those who have a normal response to either agent are very unlikely to develop subsequent adrenal insufficiency, while those with an abnormal response to insulin may normalize over time and should receive further testing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41413?source=see_link\">",
"     \"Diagnosis of hypopituitarism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/46/44777?source=see_link\">",
"     \"Diagnosis of adrenal insufficiency in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is important to recognize that specific recommended cut-off levels for cortisol are based on specific assays, and may vary among assays [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/5\">",
"     5",
"    </a>",
"    ]. Ideally, criteria for an abnormal response should be validated locally, or very conservative cut-off points should be used.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient fasts for at least eight hours before the test and must remain supine during the procedure. A clinician must be present at all times. A syringe containing 50 percent glucose solution should be at the bedside. An intravenous line is established and insulin is injected intravenously. The usual dose is 0.15",
"    <span class=\"nowrap\">",
"     U/kg,",
"    </span>",
"    but different doses may be indicated in certain patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients thought to have hypopituitarism or primary adrenal insufficiency, the insulin dose is decreased to 0.1",
"      <span class=\"nowrap\">",
"       U/kg",
"      </span>",
"      because these conditions may be associated with decreased release of other counterregulatory hormones such as epinephrine and growth hormone.",
"     </li>",
"     <li>",
"      In patients with obesity, diabetes mellitus, suspected acromegaly or Cushing's syndrome, the dose is increased to 0.25",
"      <span class=\"nowrap\">",
"       U/kg",
"      </span>",
"      because insulin resistance is likely.",
"     </li>",
"     <li>",
"      In premenopausal women, the test can be performed at any phase of the menstrual cycle, as there are no cycle effects on the hypothalamic-pituitary-adrenal axis response to insulin-induced hypoglycemia [",
"      <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Blood is obtained for serum glucose and cortisol assays (and for growth hormone, if indicated) immediately before insulin is injected and 30 and 45 minutes thereafter. All patients in whom adequate hypoglycemia is achieved, defined as 35",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.9",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    or less, should have some symptoms of hypoglycemia, either of sympathetic discharge or of central nervous system glucose deprivation, such as simply falling asleep.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Almost all patients have some degree of perspiration. If the patient does not perspire, the adequacy of the stress stimulus must remain suspect irrespective of the serum glucose concentration.",
"     </li>",
"     <li>",
"      Most patients also have a hyperactive precordium (but not tachycardia or hypotension, because they are supine), and feelings of hunger, drowsiness, detachment, or anxiety. The last is common and sometimes severe, and many patients find this an unpleasant experience.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hypoglycemia usually occurs 30 to 45 minutes after insulin injection. If adequate hypoglycemia is not achieved, a second similar dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/45/8922?source=see_link\">",
"     regular insulin",
"    </a>",
"    should be injected intravenously. Adequate hypoglycemia should be achieved within the ensuing 30 to 45 minutes.",
"   </p>",
"   <p>",
"    Ideally, an automated glucose oxidase analyzer should be available at the bedside. Unfortunately, most glucose oxidase strips, whether read visually or with a glucose meter, are inaccurate at low serum glucose concentrations, tending to underestimate them, leading to premature termination of the test. The final, definitive blood sample for measurement of cortisol should be obtained 5 to 10 minutes after the patient begins to perspire or, if it can reliably be measured, when the serum glucose falls below 35",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.9",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    Some have recommended a serum glucose nadir of 45",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.4",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    or less, which appears to be adequate in most patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with primary or secondary adrenal insufficiency or long-standing diabetes mellitus have an impaired compensatory response to hypoglycemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29638?source=see_link\">",
"     \"Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Therefore, the test should be stopped when the serum glucose concentration falls to or below 35",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.9",
"      <span class=\"nowrap\">",
"       mmol/L),",
"      </span>",
"      by infusing 10 percent glucose solution in addition to giving sweetened orange juice or cola by mouth.",
"     </li>",
"     <li>",
"      A 50 percent glucose solution should be infused over a period of one minute (slowly, because of its hypertonicity) if seizure, chest pain, confusion, disorientation, or other potentially serious complications occur; this will result in hyperglycemia within 30 seconds.",
"     </li>",
"     <li>",
"      Blood should be drawn for measurement of cortisol when glucose is given, and 15 minutes later, as levels continue to increase despite increasing serum glucose concentrations [",
"      <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The impact of glucose infusion on cortisol values was illustrated in a study of hypoglycemic symptoms in 16 healthy subjects who underwent two insulin tolerance tests. Each received 500 mL of a 5 percent glucose or a 0.9 percent saline solution in a randomized fashion when the blood glucose fell to less than 40",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.2",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    The duration and severity of symptoms were reduced significantly by glucose infusion and peak cortisol levels were similar in the two tests [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/12\">",
"     12",
"    </a>",
"    ]. Although such an approach has not been validated in patients with adrenal insufficiency, it may be useful in patients with pituitary disease who may have diminished counter-regulatory responses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Normal values",
"    </span>",
"    &nbsp;&mdash;&nbsp;The criteria for a normal serum cortisol response ranged from 18 to about 22",
"    <span class=\"nowrap\">",
"     mcg/dL",
"    </span>",
"    (500 to 600",
"    <span class=\"nowrap\">",
"     nmol/L)",
"    </span>",
"    in multiple studies using different assays and various methods to establish a normal reference range [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/5,13\">",
"     5,13",
"    </a>",
"    ]. Ideally, reference ranges would be determined locally but this is rarely done in practice. If serum cortisol reaches this level, it is unimportant whether hypoglycemia was adequate. On the other hand, failure to reach this level is indicative of an inadequate response",
"    <strong>",
"     only",
"    </strong>",
"    if the serum glucose fell to 35",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.9",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    or less. If this was not achieved, the stimulus was inadequate and the test must be repeated. It is the serum cortisol concentration that is achieved rather than the increment that is important [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The serum cortisol increase parallels that of plasma ACTH up to a serum cortisol concentration of about 22",
"    <span class=\"nowrap\">",
"     mcg/dL",
"    </span>",
"    (607",
"    <span class=\"nowrap\">",
"     nmol/L),",
"    </span>",
"    corresponding to a plasma ACTH concentration of approximately 75",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    (16",
"    <span class=\"nowrap\">",
"     pmol/L),",
"    </span>",
"    which is the acute maximally stimulating plasma concentration of ACTH.",
"   </p>",
"   <p>",
"    Plasma ACTH can also be measured. The normal plasma ACTH response has not been carefully defined, but the peak concentration should exceed 150",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    (33",
"    <span class=\"nowrap\">",
"     pmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/14-18\">",
"     14-18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum growth hormone should also increase; its measurement provides another index of anterior pituitary function. Its use for the diagnosis of adult growth hormone deficiency is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/50/1833?source=see_link\">",
"     \"Growth hormone deficiency in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are only limited data regarding the salivary cortisol response to insulin hypoglycemia; this promising outcome measure requires further validation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;An inadequate cortisol response can be due to hypopituitarism of any etiology, including hypothalamic corticotropin-releasing hormone (CRH) deficiency, isolated ACTH deficiency, partial or panhypopituitarism, and acute or chronic administration of synthetic glucocorticoids; it can also be due to primary adrenal insufficiency when serum cortisol rather than plasma ACTH values are used as the end-points of the test. However, false negative results in patients who have partial adrenal insufficiency can occur because hypoglycemia is such a potent stimulus that it may obscure a partial defect.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypoglycemia is a much stronger stimulus of ACTH secretion than is hypocortisolemia (as induced by",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/12/15556?source=see_link\">",
"       metyrapone",
"      </a>",
"      ). Consequently, patients may have a normal response to hypoglycemia, but an inadequate response to metyrapone, which can detect subtle defects in ACTH secretion. The reverse is almost never true.",
"     </li>",
"     <li>",
"      The low-dose (1 mcg) one-hour ACTH stimulation test does not result in maximally stimulating plasma ACTH concentrations. Thus, as with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/12/15556?source=see_link\">",
"       metyrapone",
"      </a>",
"      , patients may have a normal serum cortisol response to hypoglycemia (or to the high-dose cosyntropin test), but an inadequate response to low-dose cosyntropin.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Previous use in Cushing's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;It was once claimed that the failure of the pituitary to respond to hypoglycemia with increased secretion of growth hormone and ACTH (as assessed by the serum cortisol concentration) was a unique feature of Cushing's disease [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/21\">",
"     21",
"    </a>",
"    ]. However, this lack of response is characteristic of chronic hypercortisolemia of any etiology [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/22\">",
"     22",
"    </a>",
"    ]. The response is also blunted in alcoholic patients with pseudo-Cushing's syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/23\">",
"     23",
"    </a>",
"    ]. Severely depressed patients who have mild hypercortisolemia of relatively short duration may have a normal plasma ACTH response to hypoglycemia, but a blunted growth response is now known to occur in many of these patients, particularly depressed postmenopausal women [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21830/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The results of the insulin-induced hypoglycemia test in these patients are nonspecific and this test has",
"    <strong>",
"     no place",
"    </strong>",
"    in the evaluation of patients with suspected Cushing's syndrome of any cause.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1825236\">",
"    <span class=\"h2\">",
"     Use in growth hormone deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of the insulin-induced hypoglycemia test for the diagnosis of growth hormone deficiency in adults is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/50/1833?source=see_link&amp;anchor=H12#H12\">",
"     \"Growth hormone deficiency in adults\", section on 'Provocative tests'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1823921\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although insulin-induced hypoglycemia is a valid, and perhaps the most rational, test of hypothalamic-pituitary-adrenal response to stress, there is little, if any, reason for performing the test except in patients with suspected recent ACTH deficiency (eg, recent pituitary surgery) or in patients with suspected growth hormone and ACTH deficiency.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The test is safe, if a clinician is present, in patients with no history of seizures or cardiovascular or cerebrovascular disease, but otherwise should not be performed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Insulin (usually at a dose of 0.15",
"      <span class=\"nowrap\">",
"       U/kg",
"      </span>",
"      [in patients with low basal cortisol levels, the dose should be reduced to 0.1",
"      <span class=\"nowrap\">",
"       U/kg])",
"      </span>",
"      is given with the aim to achieve hypoglycemia of 35",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.9",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      or less.",
"     </li>",
"     <li>",
"      Cortisol concentrations are measured at 0, 30, and 45 minutes after insulin is given and, when appropriate, 15 minutes after glucose has been given to reduce symptoms of hypoglycemia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The criteria for a normal serum cortisol response range from 18 to about 22",
"      <span class=\"nowrap\">",
"       mcg/dL",
"      </span>",
"      (500 to 600",
"      <span class=\"nowrap\">",
"       nmol/L)",
"      </span>",
"      in studies using different assays and various methods to establish a normal reference range. Failure to reach this level is indicative of an inadequate response",
"      <strong>",
"       only",
"      </strong>",
"      if the serum glucose fell to 35",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.9",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      or less. If this degree of hypoglycemia was not achieved, and the cortisol is inadequate, the stimulus was inadequate and the test must be repeated. It is the peak serum cortisol concentration that is achieved rather than the increment that is important.",
"     </li>",
"     <li>",
"      An inadequate cortisol response can be due to hypopituitarism of any etiology, including hypothalamic corticotropin-releasing hormone (CRH) deficiency, isolated ACTH deficiency, partial or panhypopituitarism, and acute or chronic administration of synthetic glucocorticoids; it can also be due to primary adrenal insufficiency. However, false negative results in patients who have partial adrenal insufficiency can occur because hypoglycemia is such a potent stimulus that it may obscure a partial defect.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/1\">",
"      D&ouml;kmeta HS, Colak R, Keletimur F, et al. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery. J Clin Endocrinol Metab 2000; 85:3713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/2\">",
"      Courtney CH, McAllister AS, McCance DR, et al. The insulin hypoglycaemia and overnight metyrapone tests in the assessment of the hypothalamic-pituitary-adrenal axis following pituitary surgery. Clin Endocrinol (Oxf) 2000; 53:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/3\">",
"      Berg C, Meinel T, Lahner H, et al. Recovery of pituitary function in the late-postoperative phase after pituitary surgery: results of dynamic testing in patients with pituitary disease by insulin tolerance test 3 and 12 months after surgery. Eur J Endocrinol 2010; 162:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/4\">",
"      Klose M, Lange M, Kosteljanetz M, et al. Adrenocortical insufficiency after pituitary surgery: an audit of the reliability of the conventional short synacthen test. Clin Endocrinol (Oxf) 2005; 63:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/5\">",
"      Agha A, Tomlinson JW, Clark PM, et al. The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 2006; 91:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/6\">",
"      Jayasena CN, Gadhvi KA, Gohel B, et al. Day 5 morning serum cortisol predicts hypothalamic-pituitary-adrenal function after transsphenoidal surgery for pituitary tumors. Clin Chem 2009; 55:972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/7\">",
"      Watts NB, Tindall GT. Rapid assessment of corticotropin reserve after pituitary surgery. JAMA 1988; 259:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/8\">",
"      Auchus RJ, Shewbridge RK, Shepherd MD. Which patients benefit from provocative adrenal testing after transsphenoidal pituitary surgery? Clin Endocrinol (Oxf) 1997; 46:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/9\">",
"      Long TD, Ellingrod VL, Kathol RG, et al. Lack of menstrual cycle effects on hypothalamic-pituitary-adrenal axis response to insulin-induced hypoglycaemia. Clin Endocrinol (Oxf) 2000; 52:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/10\">",
"      Streeten DH, Anderson GH Jr, Dalakos TG, et al. Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man. Endocr Rev 1984; 5:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/11\">",
"      Erturk E, Jaffe CA, Barkan AL. Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test. J Clin Endocrinol Metab 1998; 83:2350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/12\">",
"      Borm K, Slawik M, Beuschlein F, et al. Low-dose glucose infusion after achieving critical hypoglycemia during insulin tolerance testing: effects on time of hypoglycemia, neuroendocrine stress response and patient's discomfort in a pilot study. Eur J Endocrinol 2005; 153:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/13\">",
"      Nieman LK. Dynamic evaluation of adrenal hypofunction. J Endocrinol Invest 2003; 26:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/14\">",
"      Staub JJ, Jenkins JS, Ratcliffe JG, Landon J. Comparison of corticotrophin and corticosteroid response to lysine vasopressin, insulin, and pyrogen in man. Br Med J 1973; 1:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/15\">",
"      Fleisher MR, Glass D, Bitensky L, et al. Plasma corticotrophin levels during insulin-hypoglycaemia: comparison of radioimmunoassay and cytochemical bioassay. Clin Endocrinol (Oxf) 1974; 3:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/16\">",
"      Donald RA. Plasma immunoreactive corticotrophin and cortisol response to insulin hypoglycemia in normal subjects and patients with pituitary disease. J Clin Endocrinol Metab 1971; 32:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/17\">",
"      Krieger DT, Liotta AS, Suda T, et al. Human plasma immunoreactive lipotropin and adrenocorticotropin in normal subjects and in patients with pituitary-adrenal disease. J Clin Endocrinol Metab 1979; 48:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/18\">",
"      DeCherney GS, DeBold CR, Jackson RV, et al. Effect of ovine corticotropin-releasing hormone administered during insulin-induced hypoglycemia on plasma adrenocorticotropin and cortisol. J Clin Endocrinol Metab 1987; 64:1211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/19\">",
"      Perogamvros I, Owen LJ, Keevil BG, et al. Measurement of salivary cortisol with liquid chromatography-tandem mass spectrometry in patients undergoing dynamic endocrine testing. Clin Endocrinol (Oxf) 2010; 72:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/20\">",
"      Deutschbein T, Unger N, Mann K, Petersenn S. Diagnosis of secondary adrenal insufficiency in patients with hypothalamic-pituitary disease: comparison between serum and salivary cortisol during the high-dose short synacthen test. Eur J Endocrinol 2009; 160:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/21\">",
"      James VH, Landon J, Wynn V, Greenwood FC. A fundamental defect of adrenocortical control in Cushing's disease. J Endocrinol 1968; 40:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/22\">",
"      Tyrrell JB, Wiener-Kronish J, Lorenzi M, et al. Cushing's disease: growth hormone response to hypoglycemia after correction of hypercortisolism. J Clin Endocrinol Metab 1977; 44:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/23\">",
"      Berman JD, Cook DM, Buchman M, Keith LD. Diminished adrenocorticotropin response to insulin-induced hypoglycemia in nondepressed, actively drinking male alcoholics. J Clin Endocrinol Metab 1990; 71:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21830/abstract/24\">",
"      Gruen PH, Sachar EJ, Altman N, Sassin J. Growth hormone responses to hypoglycemia in postmenopausal depressed women. Arch Gen Psychiatry 1975; 32:31.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 164 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-27.109.116.13-FFFC22E1CE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_20_21830=[""].join("\n");
var outline_f21_20_21830=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1823921\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INSULIN-INDUCED HYPOGLYCEMIA TEST",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1824008\">",
"      Stress response",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1824015\">",
"      Advantages/disadvantages",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H727077\">",
"      Suggested use",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H621972649\">",
"      - After pituitary surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Procedure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Normal values",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Interpretation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Previous use in Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1825236\">",
"      Use in growth hormone deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1823921\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/46/44777?source=related_link\">",
"      Diagnosis of adrenal insufficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41413?source=related_link\">",
"      Diagnosis of hypopituitarism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21913?source=related_link\">",
"      Establishing the diagnosis of Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/20/24905?source=related_link\">",
"      Evaluation of the response to ACTH in adrenal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/50/1833?source=related_link\">",
"      Growth hormone deficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29638?source=related_link\">",
"      Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_20_21831="Chronic eosinophilic pneumonia CXR";
var content_f21_20_21831=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F86465&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F86465&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1130px;\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Chronic eosinophilic pneumonia chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 528px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Classic findings of chronic eosinophilic pneumonia (CEP) as seen on a&nbsp;conventional chest radiograph. The findings include bilateral, upper lobe predominant, and&nbsp;peripheral consolidative and ground-glass opacities. In CEP, lung involvement is bilateral in&nbsp;75 percent and confined to the upper lobe in&nbsp;50 percent. While these findings are \"classic\", it should be recognized that the chest imaging findings in most cases of CEP are not classic.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David A Lynch, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_20_21831=[""].join("\n");
var outline_f21_20_21831=null;
var title_f21_20_21832="Evaluation of the patient with hyponatremia";
var content_f21_20_21832=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of the patient with hyponatremia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/20/21832/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/20/21832/contributors\">",
"     Richard H Sterns, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/20/21832/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/20/21832/contributors\">",
"     Michael Emmett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/20/21832/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/20/21832/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/20/21832/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyponatremia is commonly defined as a serum sodium concentration below 135",
"    <span class=\"nowrap\">",
"     meq/L,",
"    </span>",
"    but can vary to a small degree in different clinical laboratories [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/1\">",
"     1",
"    </a>",
"    ]. In virtually all patients, hyponatremia results from the intake (either oral or intravenous) and subsequent retention of water [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/2\">",
"     2",
"    </a>",
"    ]. A water load will, in normal individuals, be rapidly excreted as the dilutional fall in serum osmolality suppresses the release of antidiuretic hormone ADH, also called vasopressin, (",
"    <a class=\"graphic graphic_figure graphicRef65195 \" href=\"UTD.htm?14/61/15325\">",
"     figure 1",
"    </a>",
"    ), thereby allowing excretion of the excess water in a dilute urine.",
"   </p>",
"   <p>",
"    In contrast to the response in normal individuals, patients who develop hyponatremia typically have an impairment in renal water excretion, most often due to an inability to suppress ADH secretion. An uncommon exception occurs in patients with primary polydipsia who can become hyponatremic because they drink such large quantities of fluid that they overwhelm the excretory capacity of the kidney even though ADH release is appropriately suppressed.",
"   </p>",
"   <p>",
"    The diagnostic approach to the patient with hyponatremia will be reviewed here. Most patients with hyponatremia have a single cause but, in selected patients, multiple factors contribute to the fall in plasma sodium. Symptomatic infection with human immunodeficiency virus (HIV) is an example of this phenomenon, as volume depletion, the syndrome of inappropriate ADH secretion, and adrenal insufficiency all may be present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39332?source=see_link\">",
"     \"Electrolyte disturbances with HIV infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The causes and treatment of hyponatremia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3562?source=see_link\">",
"     \"Causes of hyponatremia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18986?source=see_link\">",
"     \"Overview of the treatment of hyponatremia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/57/17306?source=see_link\">",
"     \"Treatment of hyponatremia: Syndrome of inappropriate antidiuretic hormone secretion (SIADH) and reset osmostat\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic approach to the patient with hyponatremia consists of a directed history and physical examination, appropriate laboratory tests, and, in selected patients, assessing the response to volume expansion with isotonic saline.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     History and physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history and physical examination in hyponatremic patients should be directed toward identification of findings that are typical of the particular causes of hyponatremia (",
"    <a class=\"graphic graphic_table graphicRef77603 \" href=\"UTD.htm?24/6/24684\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/2-4\">",
"     2-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A history of fluid loss (eg, vomiting, diarrhea, diuretic therapy) and, on examination, signs of extracellular volume depletion, such as decreased skin turgor, a low jugular venous pressure (which is not diagnostic), or orthostatic or persistent hypotension. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/56/24457?source=see_link\">",
"       \"Etiology, clinical manifestations, and diagnosis of volume depletion in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Signs of peripheral edema",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ascites, which can be due to heart failure, cirrhosis, or renal failure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/36/34375?source=see_link\">",
"       \"Clinical manifestations and diagnosis of edema in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19945?source=see_link\">",
"       \"Evaluation of the patient with suspected heart failure\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/41/23194?source=see_link\">",
"       \"Diagnostic approach to the patient with cirrhosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A history consistent with one of the causes of SIADH, such as small cell carcinoma or central nervous system disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/46/7913?source=see_link\">",
"       \"Pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Symptoms and signs suggestive of adrenal insufficiency or hypothyroidism. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/46/44777?source=see_link\">",
"       \"Diagnosis of adrenal insufficiency in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26744?source=see_link\">",
"       \"Diagnosis of and screening for hypothyroidism\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although the history and physical examination often provide important clues to the cause of hyponatremia, identification of subtle degrees of volume depletion or edema may be difficult [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. As a result, laboratory testing is almost always required to establish the diagnosis, particularly measurement of the urine sodium concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three laboratory tests provide important initial information in the differential diagnosis of hyponatremia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Serum osmolality",
"     </li>",
"     <li>",
"      Urine osmolality",
"     </li>",
"     <li>",
"      Urine sodium, potassium, and chloride concentrations",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Serum osmolality",
"    </span>",
"    &nbsp;&mdash;&nbsp;The serum osmolality (Sosm), which normally ranges from 275 to 290",
"    <span class=\"nowrap\">",
"     mosmol/kg,",
"    </span>",
"    is reduced in most hyponatremic patients, because it is primarily determined by the serum sodium concentration and accompanying anions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3562?source=see_link&amp;anchor=H5#H5\">",
"     \"Causes of hyponatremia\", section on 'Hyponatremia with a low serum osmolality'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The Sosm is part of the routine evaluation in patients with hyponatremia because some have an Sosm that is high or normal. These disorders are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3562?source=see_link&amp;anchor=H16#H16\">",
"     \"Causes of hyponatremia\", section on 'Hyponatremia with a high or normal serum osmolality'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The three most common causes of hyponatremia with a high or normal Sosm are marked hyperglycemia, severe azotemia, and alcohol intoxication:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hyperglycemia  In patients with marked hyperglycemia, which is almost always a manifestation of uncontrolled diabetes, the increase in serum glucose raises the Sosm, which pulls water out of the cells and lowers the serum sodium concentration. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/55/4986?source=see_link&amp;anchor=H16#H16\">",
"       \"Clinical features and diagnosis of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults\", section on 'Serum sodium'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Azotemia  In patients with advanced renal failure, the hyponatremia is due to an inability to excrete water resulting from the impairment in renal function. Although this will tend to lower the Sosm, this effect is counterbalanced to a variable degree by the associated elevation in blood urea nitrogen (BUN), resulting in an Sosm that may be normal or elevated. However, there is a difference between the measured serum osmolality and the effective serum osmolality in patients with renal failure. In contrast to sodium and glucose, urea is an ineffective osmole, since it can freely cross cell membranes and therefore does not obligate water movement out of the cells. Thus, patients with hyponatremia and renal failure have a low effective serum osmolality (Sosm) that becomes apparent if the measured Sosm is corrected for the effect of urea:",
"      <br/>",
"      <br/>",
"      Corrected Sosm &nbsp;= &nbsp;Measured Sosm &nbsp;- &nbsp;(BUN &nbsp;&divide; &nbsp;2.8)",
"      <br/>",
"      <br/>",
"      Dividing the BUN by 2.8 converts",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      into",
"      <span class=\"nowrap\">",
"       mmol/L,",
"      </span>",
"      which is required when measuring osmolality. In countries in which blood urea is measured in units of",
"      <span class=\"nowrap\">",
"       mmol/L,",
"      </span>",
"      the formula is:",
"      <br/>",
"      <br/>",
"      Corrected Sosm &nbsp;= &nbsp;Measured Sosm &nbsp;- &nbsp;blood urea concentration",
"     </li>",
"     <li>",
"      Alcohol intoxication  True hyponatremia is common in patients with alcoholism. The reduction in the Sosm associated with hyponatremia can be offset in some patients by high circulating levels of ethanol. Ethanol, like urea, is an ineffective osmole since it can freely cross cell membranes and therefore does not obligate water movement out of cells. Thus, patients with hyponatremia and alcoholism may have a low serum sodium concentration, a low calculated Sosm, but a measured Sosm that is not low [",
"      <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/6\">",
"       6",
"      </a>",
"      ] . The reason for the gap between the calculated and measured Sosm becomes apparent when the blood alcohol level is measured. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/29/41430?source=see_link&amp;anchor=H3#H3\">",
"       \"Serum osmolal gap\", section on 'Ethanol intoxication'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Less common causes of hyponatremia with a high or normal Sosm include infusion or absorption of solutions containing sugars that act as effective osmoles, systemic absorption of irrigant solutions containing glycine,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/0/29699?source=see_link\">",
"     sorbitol",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/42/3752?source=see_link\">",
"     mannitol",
"    </a>",
"    , and pseudohyponatremia due to hyperlipidemia or hyperproteinemia:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intravenous infusions of sugars  Administration of either hypertonic",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/42/3752?source=see_link\">",
"       mannitol",
"      </a>",
"      or maltose or sucrose in conjunction with intravenous immune globulin will cause hyponatremia in patients with renal failure. In such patients, these sugars are retained and, because they are effective osmoles, pull water out of cells and thereby lower the serum sodium concentration. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32451?source=see_link\">",
"       \"Complications of mannitol therapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Irrigant absorption  The absorption of nonconductive glycine,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/0/29699?source=see_link\">",
"       sorbitol",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/42/3752?source=see_link\">",
"       mannitol",
"      </a>",
"      irrigation solutions during transurethral resection of the prostate or bladder (called the transurethral resection syndrome) or during hysteroscopy or laparoscopic surgery can lower the serum sodium by increasing the extracellular fluid volume with these sodium free solutions. These disorders are discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/41/8858?source=see_link&amp;anchor=H16#H16\">",
"       \"Hyponatremia following transurethral resection or hysteroscopy\", section on 'Pathogenesis of neurologic symptoms'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22951?source=see_link\">",
"       \"Hysteroscopy: Managing fluid and gas distending media\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pseudohyponatremia  Hyperlipidemia or hyperproteinemia lower the serum sodium concentration (and therefore the calculated Sosm) without changing the measured Sosm [",
"      <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/7\">",
"       7",
"      </a>",
"      ]. This laboratory artifact is called pseudohyponatremia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3562?source=see_link&amp;anchor=H21#H21\">",
"       \"Causes of hyponatremia\", section on 'Pseudohyponatremia'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H4352294\">",
"       'Ion-selective electrodes'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4352294\">",
"    <span class=\"h4\">",
"     Ion-selective electrodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;In normal individuals, each liter of plasma is approximately 93 percent water, with fats and proteins accounting for the remaining 7 percent. Thus, a normal serum sodium concentration of 142",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (measured per liter of plasma) actually represents a concentration in the physiologically important plasma water of 154",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (142 &nbsp;&divide; &nbsp;0.93 &nbsp;= &nbsp;154). In patients with marked hyperlipidemia or hyperproteinemia, the proportion of the plasma that is water falls to a lower value. As a result, the sodium concentration per liter of plasma will fall, which is an artifact since the physiologically important sodium concentration per liter of plasma water is normal.",
"   </p>",
"   <p>",
"    In such patients, ion-selective electrodes will reveal a normal serum sodium concentration if an instrument employing direct potentiometry is used [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/3,8,9\">",
"     3,8,9",
"    </a>",
"    ]. However, many laboratory analyzers that measure sodium with ion-selective electrodes utilize indirect potentiometry in which the plasma sample is diluted before measurement; these analyzers will report a low sodium concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To understand why this occurs, consider an instrument that dilutes the plasma specimen 1:100 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/8\">",
"     8",
"    </a>",
"    ]. Suppose that the plasma water constitutes 80 percent of the plasma in a patient with hyperlipidemia. In this setting, each L of plasma contains 120 meq of sodium even though the plasma water sodium concentration is normal. If this is now diluted to a total volume of 100 L, there will be only 120 meq of sodium present and, correcting for dilution, the measured sodium concentration will appear reduced at 120",
"    <span class=\"nowrap\">",
"     meq/L.",
"    </span>",
"   </p>",
"   <p>",
"    Other instruments directly measure the sodium concentration without dilution. Falsely low levels may still be obtained in patients with hyperlipidemia; why this occurs is not well understood [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As an alternative to using ion selective electrodes, the water content of plasma in patients with hyperlipidemia or hyperproteinemia can be estimated from the following formula [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    &nbsp;Plasma water content, percent &nbsp; = &nbsp; 99.1 &nbsp;- &nbsp;(0.1 &nbsp;x &nbsp;L) &nbsp;- &nbsp;(0.07 &nbsp;x &nbsp;P)",
"   </p>",
"   <p>",
"    where L and P refer to the total lipid and protein concentrations in",
"    <span class=\"nowrap\">",
"     g/L,",
"    </span>",
"    respectively. This value is then adjusted to the normal value for plasma water content of 93 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Urine osmolality",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with hyponatremia and a low plasma osmolality, the urine osmolality can be used to distinguish between impaired water excretion (which is present in almost all cases) and primary polydipsia, in which water excretion is normal but intake is so high that it exceeds excretory capacity.",
"   </p>",
"   <p>",
"    The normal response to hyponatremia (which is maintained in primary polydipsia) is to markedly suppress ADH secretion, resulting in the excretion of a maximally dilute urine with an osmolality below 100",
"    <span class=\"nowrap\">",
"     mosmol/kg",
"    </span>",
"    and a specific gravity &le;1.003. Values above this level indicate an inability to normally excrete free water, most commonly because of persistent secretion of ADH. Most hyponatremic patients have a relatively marked impairment in urinary dilution that is sufficient to maintain the urine osmolality at 300",
"    <span class=\"nowrap\">",
"     mosmol/kg",
"    </span>",
"    or higher. The primary causes of persistent ADH release are effective circulating volume depletion (true hypovolemia, heart failure, and cirrhosis) and the syndrome of inappropriate ADH secretion (SIADH). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3562?source=see_link\">",
"     \"Causes of hyponatremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are three settings other than primary polydipsia in which the urine osmolality may be below 100",
"    <span class=\"nowrap\">",
"     mosmol/kg:",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Malnutrition, described primarily in beer drinkers (called beer drinkers potomania), in which dietary solute intake (sodium, potassium, protein) and therefore solute excretion is so low that the rate of water excretion is markedly diminished even though urinary dilution is intact. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3562?source=see_link&amp;anchor=H15#H15\">",
"       \"Causes of hyponatremia\", section on 'Low dietary solute intake'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Reset osmostat in which a water load appropriately suppresses ADH release but at a lower serum osmolality than in normal individuals. The major clinical clue to the presence of this disorder, which presents with clinical features similar to the SIADH, is a moderately reduced plasma sodium concentration (usually between 125 and 135",
"      <span class=\"nowrap\">",
"       meq/L)",
"      </span>",
"      that is stable on multiple measurements. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/57/17306?source=see_link&amp;anchor=H23#H23\">",
"       \"Treatment of hyponatremia: Syndrome of inappropriate antidiuretic hormone secretion (SIADH) and reset osmostat\", section on 'Reset osmostat'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The urine osmolality will also be below 100",
"      <span class=\"nowrap\">",
"       mosmol/kg",
"      </span>",
"      if it is measured after the reason for ADH release has been corrected (eg, following volume expansion with isotonic saline in a patient with hypovolemia or reversal of SIADH by cessation of an offending drug or glucocorticoid replacement in adrenal insufficiency). In such patients, the low urine osmolality heralds the spontaneous and rapid correction of hyponatremia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18986?source=see_link&amp;anchor=H3#H3\">",
"       \"Overview of the treatment of hyponatremia\", section on 'Treat the underlying disease'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Urine sodium and chloride concentration",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with hyponatremia, hypoosmolality, and an inappropriately concentrated urine, the urine sodium and, in certain settings, the urine chloride concentrations can be used to distinguish between hyponatremia caused by effective circulating volume depletion (true hypovolemia, heart failure, and cirrhosis) and that caused by euvolemic hyponatremia (most often due to SIADH) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The urine sodium concentration is usually below 25",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      in hypovolemia, unless there is renal salt-wasting, due most often to diuretic therapy and infrequently to adrenal insufficiency or cerebral salt-wasting [",
"      <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/5\">",
"       5",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8567?source=see_link\">",
"       \"Cerebral salt-wasting\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The urine sodium concentration is usually above 40",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      in patients with the SIADH who are normovolemic and whose rate of sodium excretion is determined by sodium intake, as it is in normal individuals [",
"      <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/5,11,12\">",
"       5,11,12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In hypovolemic hyponatremic patients who have metabolic alkalosis caused by vomiting, the urine sodium concentration may be greater than 25",
"      <span class=\"nowrap\">",
"       meq/L,",
"      </span>",
"      but the urine chloride concentration will be low (less than 25",
"      <span class=\"nowrap\">",
"       meq/L).",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnostic value of the urine sodium concentration was illustrated in a study of 58 hyponatremic patients without edema [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/5\">",
"     5",
"    </a>",
"    ]. The mean urine sodium concentration was 18",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    in patients who were judged to be hypovolemic (as determined by a significant rise in serum sodium following isotonic saline) compared to 72",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    in those with SIADH (as determined by no increase in serum sodium following isotonic saline). In contrast to the utility of the urine sodium concentration, clinical assessment of volume status correctly identified only 48 percent of patients.",
"   </p>",
"   <p>",
"    In addition to the initial value, serial monitoring of the urine sodium concentration may be helpful in selected cases in which the correct diagnosis may not be apparent. Suppose, for example, that the urine sodium concentration falls from 50 to 10",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    following the administration of 1 to 2 L of isotonic saline. Surreptitious diuretic ingestion should be suspected in this setting. The urine sodium concentration was elevated on the first measurement because of the action of the diuretic. Once this wore off, the true state of volume depletion was unmasked even though the hypovolemia had been partially corrected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/31/502?source=see_link\">",
"     \"Diuretic-induced hyponatremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In another example, suppose that the initial urine sodium concentration is 35",
"    <span class=\"nowrap\">",
"     meq/L,",
"    </span>",
"    an intermediate value that could be seen with either true hypovolemia (ie, not heart failure or cirrhosis) or SIADH. Serial monitoring of the urine osmolality and urine sodium concentration in response to the administration of isotonic saline can help clarify the diagnosis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the patient is hypovolemic, isotonic saline should suppress the hypovolemic stimulus to ADH release, promoting the excretion of a dilute urine (urine osmolality usually less than 100",
"      <span class=\"nowrap\">",
"       mosmol/kg)",
"      </span>",
"      and rapid correction of the hyponatremia.",
"     </li>",
"     <li>",
"      If the patient has SIADH, ADH release occurs independently of the volume status and the urine osmolality will remain elevated following isotonic saline therapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In both disorders, the urine sodium concentration will increase with saline therapy, although the increase in hypovolemic patients will not be seen until the hypovolemia is mostly corrected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H387448011\">",
"    <span class=\"h3\">",
"     Urine to serum electrolyte ratio",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sum of the urine sodium plus potassium concentrations divided by the serum sodium concentration has been called the urine to serum (or urine to plasma) electrolyte ratio [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/13\">",
"     13",
"    </a>",
"    ]. A ratio less than 0.5 (meaning that the tonicity of the urine is likely less than half that of the serum) indicates that urinary losses of electrolyte-free water are high and that fluid restriction may therefore be effective. In contrast, a urine to serum electrolyte ratio greater than 1 indicates that the urine is hypertonic compared to the serum and that other therapeutic measures in addition to fluid restriction will be necessary to correct the hyponatremia. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Fractional excretion of sodium",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with acute kidney injury, the fractional excretion of sodium (FENa) provides a more accurate assessment of volume status than the urine sodium concentration because it corrects for the effect that variations in urine volume have on the urine sodium. A FENa below 1 percent suggests effective volume depletion, while a value about 2 percent suggests acute tubular necrosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/17/8472?source=see_link\">",
"     \"Fractional excretion of sodium, urea, and other molecules in acute kidney injury (acute renal failure)\"",
"    </a>",
"    .),",
"   </p>",
"   <p>",
"    This observation has led some clinicians to use the FENa in any situation in which measurement of the urine sodium concentration might be helpful. Calculators for the FENa are available using either standard units (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?25/13/25809?source=see_link\">",
"     calculator 1",
"    </a>",
"    ) or SI units (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?24/28/25025?source=see_link\">",
"     calculator 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    However, such an approach can lead to an erroneous diagnosis. A urine sodium concentration less than 25",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    suggests effective volume depletion independent of the glomerular filtration rate. In contrast, a FENa below 1 percent as an indicator of effective volume depletion applies",
"    <strong>",
"     only",
"    </strong>",
"    to patients with advanced renal failure; it does",
"    <strong>",
"     not",
"    </strong>",
"    apply to patients with normal or mild to moderate renal dysfunction who have a much higher glomerular filtration rate and a much greater filtered sodium load.",
"   </p>",
"   <p>",
"    As an example, patients with a normal glomerular filtration rate of 180",
"    <span class=\"nowrap\">",
"     L/day",
"    </span>",
"    (125",
"    <span class=\"nowrap\">",
"     mL/min)",
"    </span>",
"    have a filtered sodium load of approximately 27,000",
"    <span class=\"nowrap\">",
"     meq/day",
"    </span>",
"    at a normal serum sodium concentration. The FENa that is diagnostic of effective volume depletion may be as low as 0.1 percent, which represents the excretion of 27 meq of sodium per day. In contrast, patients with SIADH are euvolemic and urinary sodium excretion is roughly equal to dietary sodium intake. Since sodium intake is usually less than 270",
"    <span class=\"nowrap\">",
"     meq/day,",
"    </span>",
"    the FENa is typically less than 1 percent. These issues are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/17/8472?source=see_link\">",
"     \"Fractional excretion of sodium, urea, and other molecules in acute kidney injury (acute renal failure)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Serum uric acid and urea concentrations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial water retention and volume expansion in the SIADH is frequently associated with hypouricemia (serum uric acid concentration less than 4",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    or 238",
"    <span class=\"nowrap\">",
"     micromol/L)",
"    </span>",
"    due to increased uric acid excretion in the urine [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/11,14-16\">",
"     11,14-16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is presumed that the early volume expansion diminishes proximal sodium reabsorption, leading to a secondary decline in the net reabsorption of uric acid and increased uric acid excretion. However, stimulation of the vasopressor V1a receptor (which primarily causes vasoconstriction) may also contribute to the uric acid wasting via an uncertain mechanism. If hyponatremia is induced in normal volunteers with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/60/10184?source=see_link\">",
"     desmopressin",
"    </a>",
"    (dDAVP), an agent that stimulates the V2 receptor (which primarily mediates the antidiuretic response) but not the V1a receptor, the serum uric acid concentration does not fall as much (29 versus 53 percent) as it does in patients with a similar degree of hyponatremia caused by the SIADH (in which the native hormone stimulates both the V1a and V2 receptors) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/0/7177?source=see_link\">",
"     \"Hypouricemia: Causes and clinical significance\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hypervolemia (and perhaps V1a receptor stimulation) also increases urinary urea clearance. Thus, in hyponatremia due to SIADH, the blood urea nitrogen (BUN) is usually less than 5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.8",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/15,18\">",
"     15,18",
"    </a>",
"    ]. However, in older patients with SIADH, the BUN is seldom this low because of the decreased fractional excretion of urea that occurs with aging [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/19\">",
"     19",
"    </a>",
"    ]. Thus, the absence of a low BUN cannot be used to exclude SIADH in older patients.",
"   </p>",
"   <p>",
"    Similar reductions in uric acid and urea levels can occur in patients with thiazide diuretic-induced hyponatremia in whom water overload, rather than volume depletion, is the primary cause of the hyponatremia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/31/502?source=see_link&amp;anchor=H4#H4\">",
"     \"Diuretic-induced hyponatremia\", section on 'Impaired water excretion'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Acid-base and potassium balance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of acid-base and potassium balance may be helpful in selected hyponatremic patients in whom the diagnosis is not apparent. As examples, metabolic alkalosis and hypokalemia suggest diuretic use or vomiting, metabolic acidosis and hypokalemia suggest diarrhea or laxative abuse, and metabolic acidosis and hyperkalemia suggest primary adrenal insufficiency in patients without renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/17/25876?source=see_link\">",
"     \"Hyponatremia and hyperkalemia in adrenal insufficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On the other hand, the serum bicarbonate and potassium concentrations are typically normal in the SIADH [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/11\">",
"     11",
"    </a>",
"    ]. Although water retention tends to lower these values by dilution (as it does the plasma sodium and chloride concentrations), normal levels are restored by the factors that regulate acid-base and potassium balance. The release of potassium from cells in an attempt to minimize cell swelling induced by hypoosmolality is an additional factor that will raise the serum potassium concentration to normal [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/11\">",
"     11",
"    </a>",
"    ] and increased acid excretion due to mild hyperaldosteronism induced by hyponatremia can raise the plasma bicarbonate concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/11,21\">",
"     11,21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/58/23464?source=see_link\">",
"     \"Manifestations of hyponatremia and hypernatremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with hypopituitarism develop hyponatremia with many features of the SIADH (including normal serum potassium and low BUN and serum uric acid) because they lack cortisol but not aldosterone. However, they tend to have slightly lower plasma bicarbonate concentrations than do other patients with the SIADH, most likely because of lower plasma aldosterone levels [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Findings in SIADH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the importance of diagnosing the SIADH in patients with hyponatremia, it is worthwhile to summarize the general findings in this disorder and the laboratory tests that should be performed [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21832/abstract/22\">",
"     22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A low serum osmolality",
"     </li>",
"     <li>",
"      An inappropriately elevated urine osmolality (above 100",
"      <span class=\"nowrap\">",
"       mosmol/kg",
"      </span>",
"      and usually above 300",
"      <span class=\"nowrap\">",
"       mosmol/kg)",
"      </span>",
"     </li>",
"     <li>",
"      A urine sodium concentration usually above 40",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"     </li>",
"     <li>",
"      Low blood urea nitrogen and serum uric acid concentration",
"     </li>",
"     <li>",
"      A relatively normal serum creatinine concentration",
"     </li>",
"     <li>",
"      Normal acid-base and potassium balance",
"     </li>",
"     <li>",
"      Normal adrenal and thyroid function",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/46/7913?source=see_link\">",
"     \"Pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As noted above, patients with SIADH will have a low urine sodium concentration if they are also volume depleted or if their sodium intake is extremely low. In such patients, the diagnosis of SIADH is made by observing the response to a saline load: the urine sodium rises as the hypovolemia is corrected but the urine osmolality remains high. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Urine sodium and chloride concentration'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Measurement of plasma ADH levels has",
"    <strong>",
"     no",
"    </strong>",
"    role in the routine diagnosis of SIADH.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/20/9537?source=see_link\">",
"       \"Patient information: Hyponatremia (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of hyponatremia is based upon a combination of findings on history, physical examination, appropriate laboratory tests, and, in selected patients, assessing the response to volume expansion with isotonic saline.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The history and physical examination in hyponatremic patients should be directed toward identification of findings that are typical of the particular causes of hyponatremia and assessment of volume status (",
"      <a class=\"graphic graphic_table graphicRef77603 \" href=\"UTD.htm?24/6/24684\">",
"       table 1",
"      </a>",
"      ). These include a history of fluid loss with associated clinical findings, an edematous state such as heart failure or cirrhosis, or a cause of the syndrome of inappropriate antidiuretic hormone (ADH) secretion. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'History and physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the initial evaluation, we recommend obtaining six laboratory tests: chemistry panel, serum osmolality, urine osmolality, and urine sodium, potassium, and chloride concentrations.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Chemistry panel &ndash; A laboratory panel that includes serum electrolytes, urea nitrogen, creatinine, and glucose concentrations may identify hyponatremia due to hyperglycemia or renal failure. In addition, low or high serum potassium or bicarbonate concentrations may be useful. As an example, hypokalemia and metabolic acidosis favor diarrhea or laxative abuse as the cause of hyponatremia, while hypokalemia and metabolic alkalosis suggest vomiting or diuretic therapy. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Acid-base and potassium balance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Serum osmolality &ndash; Most cases of hyponatremia are associated with a reduced serum osmolality (Sosm), since sodium salts are the main determinant of Sosm. However, the Sosm can be normal or elevated in selected causes of hyponatremia (",
"      <a class=\"graphic graphic_table graphicRef77603 \" href=\"UTD.htm?24/6/24684\">",
"       table 1",
"      </a>",
"      ). The most important causes are marked hyperglycemia in patients with uncontrolled diabetic mellitus and advanced renal failure. In patients with renal failure, the increase in Sosm above that expected from the serum sodium concentration is due to the retention of urea, which is an ineffective osmole since it equilibrates across the cells. These patients have a low effective serum osmolality if the osmotic contribution of urea is subtracted from the measured value. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Serum osmolality'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Urine osmolality &ndash; A urine osmolality (Uosm) of more than",
"      <strong>",
"       100",
"      </strong>",
"      <span class=\"nowrap\">",
"       mosmol/kg",
"      </span>",
"      (and usually substantially higher) is consistent with an inability to normally excrete free water, which is generally due to continued secretion of ADH (",
"      <a class=\"graphic graphic_table graphicRef77603 \" href=\"UTD.htm?24/6/24684\">",
"       table 1",
"      </a>",
"      ). A Uosm less than 100",
"      <span class=\"nowrap\">",
"       mosmol/kg",
"      </span>",
"      indicates appropriate suppression of ADH may be due to primary polydipsia or certain other causes. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Urine osmolality'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Urine sodium and chloride concentrations &ndash; The urine sodium concentration is used to help distinguish between effective volume depletion and other causes of hyponatremia in which normovolemia is present. The urine sodium should be less than",
"      <strong>",
"       25",
"      </strong>",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      with hypovolemia unless there is salt wasting due, for example, to diuretic therapy. By comparison, the urine sodium is generally above",
"      <strong>",
"       40",
"      </strong>",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      in the SIADH. In patients with intermediate values, serial monitoring of the urine sodium concentration in response to isotonic saline should be performed. The urine chloride rather than the urine sodium is used to identify volume depletion in patients with metabolic alkalosis due to gastric fluid losses. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Urine sodium and chloride concentration'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Urine to serum electrolyte ratio &ndash; The sum of urine sodium plus potassium divided by the serum sodium concentration is helpful in predicting the response of the serum sodium concentration to therapeutic fluid restriction. (See",
"      <a class=\"local\" href=\"#H387448011\">",
"       'Urine to serum electrolyte ratio'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients in whom the diagnosis is not apparent after the above initial evaluation, measurement of the serum uric acid and urea concentrations, the fractional excretion of sodium, and adrenal and thyroid function tests may be helpful. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Serum uric acid and urea concentrations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of SIADH is usually made from the history, physical examination (no edema or signs of hypovolemia), and laboratory tests. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Findings in SIADH'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/1\">",
"      Adrogu&eacute; HJ, Madias NE. Hyponatremia. N Engl J Med 2000; 342:1581.",
"     </a>",
"    </li>",
"    <li>",
"     Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York 2001. p.720.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/3\">",
"      Yeates KE, Singer M, Morton AR. Salt and water: a simple approach to hyponatremia. CMAJ 2004; 170:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/4\">",
"      Verbalis JG, Goldsmith SR, Greenberg A, et al. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med 2007; 120:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/5\">",
"      Chung HM, Kluge R, Schrier RW, Anderson RJ. Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med 1987; 83:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/6\">",
"      Purssell RA, Pudek M, Brubacher J, Abu-Laban RB. Derivation and validation of a formula to calculate the contribution of ethanol to the osmolal gap. Ann Emerg Med 2001; 38:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/7\">",
"      Turchin A, Seifter JL, Seely EW. Clinical problem-solving. Mind the gap. N Engl J Med 2003; 349:1465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/8\">",
"      Weisberg LS. Pseudohyponatremia: a reappraisal. Am J Med 1989; 86:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/9\">",
"      Nguyen MK, Ornekian V, Butch AW, Kurtz I. A new method for determining plasma water content: application in pseudohyponatremia. Am J Physiol Renal Physiol 2007; 292:F1652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/10\">",
"      McDonald, DA. Effects of protein and triglycerides on serum sodium and potassium values obtained by the Kodak dry film potentiometric technique. Can J Med Technol 1986; 48:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/11\">",
"      Graber M, Corish D. The electrolytes in hyponatremia. Am J Kidney Dis 1991; 18:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/12\">",
"      Palmer BF. Hyponatraemia in a neurosurgical patient: syndrome of inappropriate antidiuretic hormone secretion versus cerebral salt wasting. Nephrol Dial Transplant 2000; 15:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/13\">",
"      Furst H, Hallows KR, Post J, et al. The urine/plasma electrolyte ratio: a predictive guide to water restriction. Am J Med Sci 2000; 319:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/14\">",
"      Beck LH. Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 1979; 301:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/15\">",
"      Decaux G, Schlesser M, Coffernils M, et al. Uric acid, anion gap and urea concentration in the diagnostic approach to hyponatremia. Clin Nephrol 1994; 42:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/16\">",
"      Maesaka JK. An expanded view of SIADH, hyponatremia and hypouricemia. Clin Nephrol 1996; 46:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/17\">",
"      Decaux G, Namias B, Gulbis B, Soupart A. Evidence in hyponatremia related to inappropriate secretion of ADH that V1 receptor stimulation contributes to the increase in renal uric acid clearance. J Am Soc Nephrol 1996; 7:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/18\">",
"      Decaux G, Genette F, Mockel J. Hypouremia in the syndrome of inappropriate secretion of antidiuretic hormone. Ann Intern Med 1980; 93:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/19\">",
"      Musch W, Verfaillie L, Decaux G. Age-related increase in plasma urea level and decrease in fractional urea excretion: clinical application in the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol 2006; 1:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/20\">",
"      Sonnenblick M, Rosin AJ. Significance of the measurement of uric acid fractional clearance in diuretic induced hyponatraemia. Postgrad Med J 1986; 62:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/21\">",
"      Decaux G, Musch W, Penninckx R, Soupart A. Low plasma bicarbonate level in hyponatremia related to adrenocorticotropin deficiency. J Clin Endocrinol Metab 2003; 88:5255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21832/abstract/22\">",
"      Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 2007; 356:2064.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2354 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-183.1.191.153-22FFA76FCA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_20_21832=[""].join("\n");
var outline_f21_20_21832=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      History and physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Serum osmolality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H4352294\">",
"      Ion-selective electrodes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Urine osmolality",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Urine sodium and chloride concentration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H387448011\">",
"      - Urine to serum electrolyte ratio",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Fractional excretion of sodium",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Serum uric acid and urea concentrations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Acid-base and potassium balance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Findings in SIADH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/2354\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/2354|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/61/15325\" title=\"figure 1\">",
"      Osmoregulation of ADH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/2354|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/6/24684\" title=\"table 1\">",
"      Major causes of hyponatremia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?25/13/25809?source=related_link\" title=\"calculator 1\">",
"      Calculator: Fractional excretion of sodium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?24/28/25025?source=related_link\" title=\"calculator 2\">",
"      Calculator: Fractional excretion of sodium (SI units)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3562?source=related_link\">",
"      Causes of hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8567?source=related_link\">",
"      Cerebral salt-wasting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/55/4986?source=related_link\">",
"      Clinical features and diagnosis of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/36/34375?source=related_link\">",
"      Clinical manifestations and diagnosis of edema in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32451?source=related_link\">",
"      Complications of mannitol therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/46/44777?source=related_link\">",
"      Diagnosis of adrenal insufficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26744?source=related_link\">",
"      Diagnosis of and screening for hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/41/23194?source=related_link\">",
"      Diagnostic approach to the patient with cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/31/502?source=related_link\">",
"      Diuretic-induced hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39332?source=related_link\">",
"      Electrolyte disturbances with HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/56/24457?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of volume depletion in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19945?source=related_link\">",
"      Evaluation of the patient with suspected heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/17/8472?source=related_link\">",
"      Fractional excretion of sodium, urea, and other molecules in acute kidney injury (acute renal failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/17/25876?source=related_link\">",
"      Hyponatremia and hyperkalemia in adrenal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/41/8858?source=related_link\">",
"      Hyponatremia following transurethral resection or hysteroscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/0/7177?source=related_link\">",
"      Hypouricemia: Causes and clinical significance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22951?source=related_link\">",
"      Hysteroscopy: Managing fluid and gas distending media",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/58/23464?source=related_link\">",
"      Manifestations of hyponatremia and hypernatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18986?source=related_link\">",
"      Overview of the treatment of hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/46/7913?source=related_link\">",
"      Pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/20/9537?source=related_link\">",
"      Patient information: Hyponatremia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/29/41430?source=related_link\">",
"      Serum osmolal gap",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/57/17306?source=related_link\">",
"      Treatment of hyponatremia: Syndrome of inappropriate antidiuretic hormone secretion (SIADH) and reset osmostat",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_20_21833="Systemic chemotherapy for metastatic colorectal cancer: General principles";
var content_f21_20_21833=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Systemic chemotherapy for metastatic colorectal cancer: General principles",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/20/21833/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/20/21833/contributors\">",
"     Jeffrey W Clark, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/20/21833/contributors\">",
"     Axel Grothey, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/20/21833/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/20/21833/contributors\">",
"     Richard M Goldberg, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/20/21833/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/20/21833/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/20/21833/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 18, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H183911197\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of patients with metastatic colon or rectal cancer cannot be cured, although a subset with liver",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lung-isolated metastatic disease, local recurrence, or limited intraabdominal disease are potentially curable with surgery. For other patients with metastatic colorectal cancer (mCRC), treatment is palliative and generally consists of systemic chemotherapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link\">",
"     \"Management of potentially resectable colorectal cancer liver metastases\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13560?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Outcomes by histology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13834?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic review will cover general principles of treating mCRC, including the goals of therapy in patients with potentially resectable metastatic disease versus those with categorically unresectable disease, benefits of treatment compared to supportive care alone as well as issues related to timing and duration of treatment in patients with unresectable metastatic disease, and assessment during therapy. Data from clinical trials evaluating systemic chemotherapy for nonresectable mCRC, specific treatment recommendations for patients with unresectable mCRC, and the use of systemic therapy for the purpose of downsizing potentially resectable CRC liver metastases are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44058?source=see_link\">",
"     \"Systemic chemotherapy for nonoperable metastatic colorectal cancer: Treatment recommendations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/32/44554?source=see_link\">",
"     \"Systemic chemotherapy for metastatic colorectal cancer: Completed clinical trials\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link&amp;anchor=H9#H9\">",
"     \"Management of potentially resectable colorectal cancer liver metastases\", section on 'Conversion therapy for initially unresectable metastases'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7582384\">",
"    <span class=\"h1\">",
"     CHEMOTHERAPY OPTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;For decades, 5-fluorouracil (5-FU) was the sole active agent for advanced CRC. This has changed markedly since the year 2000, with the approval of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/41/7834?source=see_link\">",
"     irinotecan",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    , three humanized monoclonal antibodies (MoAbs) that target vascular endothelial growth factor (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"     bevacizumab",
"    </a>",
"    ) and the epidermal growth factor receptor (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/58/10151?source=see_link\">",
"     cetuximab",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/48/6918?source=see_link\">",
"     panitumumab",
"    </a>",
"    ), and most recently, intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/28/37312?source=see_link\">",
"     aflibercept",
"    </a>",
"    , a fully-humanized recombinant fusion protein consisting of vascular endothelial growth factor (VEGF) binding portions from the human VEGF receptors 1 and 2 fused to the Fc portion of human immunoglobulin G1, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32006?source=see_link\">",
"     regorafenib",
"    </a>",
"    , an orally active inhibitor of angiogenic (including the VEGF receptors 1 to 3), stromal, and oncogenic receptor tyrosine kinases. In addition, orally active fluoropyrimidines (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"     capecitabine",
"    </a>",
"    , S-1, UFT) are also available. The best way to combine and sequence these agents is still not established. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44058?source=see_link\">",
"     \"Systemic chemotherapy for nonoperable metastatic colorectal cancer: Treatment recommendations\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A compilation of commonly used chemotherapy protocols for colorectal cancer is available. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/45/10963?source=see_link\">",
"     \"Treatment protocols for colorectal cancer\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9654617\">",
"    <span class=\"h1\">",
"     TREATMENT GOALS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of chemotherapy for mCRC differ according to the clinical scenario. For most patients, treatment will be palliative and not curative (a fact that may not be understood by patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/1\">",
"     1",
"    </a>",
"    ]), and the treatment goals are to prolong overall survival and maintain quality of life (QOL) for as long as possible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9654802\">",
"    <span class=\"h2\">",
"     Potentially resectable disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;However, some patients with stage IV disease (particularly those with liver-limited metastases) can be surgically cured of their disease. Even selected patients with initially unresectable liver metastases may become eligible for resection if the response to chemotherapy is sufficient.",
"   </p>",
"   <p>",
"    This approach has been termed \"conversion therapy\" [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/2\">",
"     2",
"    </a>",
"    ] to distinguish it from \"neoadjuvant therapy\", which applies to preoperative chemotherapy given to patients who present upfront with apparently resectable disease. The key parameter for selecting the specific regimen in this scenario is not survival or improved QOL, but instead, response rate (ie, the ability of the regimen to shrink metastases) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link&amp;anchor=H9#H9\">",
"     \"Management of potentially resectable colorectal cancer liver metastases\", section on 'Conversion therapy for initially unresectable metastases'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9654809\">",
"    <span class=\"h2\">",
"     Nonresectable disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following general principles guide the use of palliative chemotherapy in the setting of nonoperable disease.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In general, for patients without symptomatic disease (ie, the majority of patients), induction of a tumor response is not as important as is delaying tumor progression for as long as possible. In the palliative setting, objective response rate is not the best indicator of treatment benefit (prolonged survival",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      progression-free survival, PFS) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/4-6\">",
"       4-6",
"      </a>",
"      ]. Thus, achieving stable disease as the best response to therapy might be considered a treatment success. (See",
"      <a class=\"local\" href=\"#H183911707\">",
"       'Assessment during therapy'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Patients benefit more from access to all active agents than from a particular treatment sequence of specific regimens used as individual \"lines\" of therapy. In all large published phase III trials over the last decade, the proportion of patients receiving all active agents correlates strongly with median survival [",
"      <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/7,8\">",
"       7,8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Because of the survival benefit from second- and even third-line chemotherapy, the routine practice of crossover in clinical trials severely limits the ability to detect an overall survival advantage of one treatment regimen over another. Therefore, the actual activity of a new agent or combination regimen is better captured by the endpoint PFS. Improvements in PFS correlate with longer survival [",
"      <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/9,10\">",
"       9,10",
"      </a>",
"      ] and are not affected by crossover or subsequent therapy.",
"      <br/>",
"      <br/>",
"      These concepts can be illustrated by results from the EPIC trial, in which patients failing initial",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"       oxaliplatin",
"      </a>",
"      -based therapy were randomly assigned to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/41/7834?source=see_link\">",
"       irinotecan",
"      </a>",
"      with or without",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/58/10151?source=see_link\">",
"       cetuximab",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/11\">",
"       11",
"      </a>",
"      ]. There were significant differences in PFS, objective response, and disease control rates that favored combined therapy, but no overall survival advantage. This was attributed to the fact that 50 percent of the patients in the irinotecan arm crossed over to cetuximab at progression. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/32/44554?source=see_link&amp;anchor=H56#H56\">",
"       \"Systemic chemotherapy for metastatic colorectal cancer: Completed clinical trials\", section on 'Cetuximab'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Endpoints other than PFS (eg, duration of disease control, time to failure of strategy) have been proposed, but none are widely used [",
"      <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/12,13\">",
"       12,13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The model of distinct \"lines\" of chemotherapy (in which regimens containing noncross-resistant drugs are each used in succession until disease progression) is being abandoned in incurable metastatic mCRC in favor of a \"continuum of care\" approach [",
"      <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/14\">",
"       14",
"      </a>",
"      ]. This implies an individualized treatment strategy that may include phases of maintenance chemotherapy interspersed with more aggressive treatment protocols, as well as reutilization of previously administered chemotherapy agents in combination with other active drugs.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following sections will emphasize the practical issues that arise when choosing the appropriate treatment strategy for individual patients with inoperable mCRC. Data from the clinical trials that support the recommendations as well as management of patients with potentially resectable liver metastases are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/32/44554?source=see_link\">",
"     \"Systemic chemotherapy for metastatic colorectal cancer: Completed clinical trials\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link\">",
"     \"Management of potentially resectable colorectal cancer liver metastases\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H183911606\">",
"    <span class=\"h1\">",
"     CHEMOTHERAPY VERSUS SUPPORTIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The median overall survival for patients with unresectable mCRC who receive best supportive care (BSC) alone is approximately five to six months. Systemic chemotherapy produces meaningful improvements in median survival and progression-free survival (PFS) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. These benefits are most pronounced with regimens containing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/41/7834?source=see_link\">",
"     irinotecan",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    in combination with 5-FU. Although no trial has compared these regimens to BSC alone, median survival now far exceeds five to six months, approaching two years.",
"   </p>",
"   <p>",
"    At least some data suggest that long-term survival may also be improving [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. As an example, in a preliminary report of pooled data from NCCTG trials conducted in the 5-FU plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/54/24423?source=see_link\">",
"     leucovorin",
"    </a>",
"    (LV) era, only 1 percent of patients were alive at five years [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/20\">",
"     20",
"    </a>",
"    ]. In contrast, in a report of patients treated in US Intergroup trial 9741 with FOLFOX4 (",
"    <a class=\"graphic graphic_table graphicRef64504 \" href=\"UTD.htm?5/20/5454\">",
"     table 1",
"    </a>",
"    ), five-year survival was 9.8 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H183911613\">",
"    <span class=\"h1\">",
"     TIMING OF CHEMOTHERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many patients with mCRC are asymptomatic. The value of early chemotherapy versus treatment deferral until symptoms develop is controversial. The only randomized trials directly addressing this issue have studied older regimens like",
"    <span class=\"nowrap\">",
"     5-FU/LV:",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In",
"      an early trial in which 182 patients with asymptomatic mCRC were randomly assigned to initial or deferred chemotherapy with sequential",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      , 5-FU, and LV, earlier treatment was associated with improvements in median survival (14 versus 9 months), symptom-free interval, and PFS [",
"      <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a combined analysis of 168 asymptomatic patients who were enrolled in two trials randomly testing early versus delayed 5-FU-based chemotherapy, there was a non-statistically significant two-month benefit in median survival with early treatment (13 versus 11 months) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Whether these results can be extrapolated to patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/41/7834?source=see_link\">",
"     irinotecan",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    , or biologic therapies, especially in the era of modern diagnostic procedures that can detect lower volume metastatic disease, is unclear. Regimens such as these are associated with clear-cut survival benefits, particularly if patients are serially exposed to all active agents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44058?source=see_link&amp;anchor=H5#H5\">",
"     \"Systemic chemotherapy for nonoperable metastatic colorectal cancer: Treatment recommendations\", section on 'Initial doublet combinations versus sequential single agent chemotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The only available data from the era of modern chemotherapy come from a retrospective report of 736 patients with mCRC diagnosed between January 2003 and December 2010 at a single Australian center; 377 (51 percent) received immediate chemotherapy, 167 (23 percent) did not because they were deemed inappropriate for therapy or refused, and 192 (26 percent) adopted a &ldquo;watch and wait&rdquo; policy initially, 168 of whom eventually received chemotherapy (at a median of 3.7 months from diagnosis) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/22\">",
"     22",
"    </a>",
"    ]. Compared to patients who received immediate treatment, the number of patients in the delayed chemotherapy group who received treatment with all active agents was similar (30 versus 39 percent) and the median survival was superior (27 versus 17 months). &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    These data are not from a randomized trial, and interpretation is limited by the potential for selection bias; ie, patients who had treatment deferred were likely to be those with favorable biology (asymptomatic, lower volume metastatic disease, better performance status), all of which could have contributed to the longer survival in this group. At least in the United States, most patients institute treatment at a time when they are still asymptomatic from their cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23214887\">",
"    <span class=\"h1\">",
"     CHEMOTHERAPY DOSING IN OBESE PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;For cancer patients with a large body surface area (BSA), chemotherapy drug doses are often reduced, because of concern for excess toxicity. However, there is no evidence that fully-dosed obese patients experience greater toxicity from chemotherapy for mCRC; furthermore, obese patients who are given reduced doses may have inferior outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/23\">",
"     23",
"    </a>",
"    ]. Although limited, the available data do not support the policy of routine dose reduction (or capping the maximal BSA to 2.0 m",
"    <sup>",
"     2",
"    </sup>",
"    ) for obese patients with mCRC. Guidelines from ASCO recommend that full weight-based cytotoxic chemotherapy doses be used to treat obese patients with cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H183911620\">",
"    <span class=\"h1\">",
"     DURATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;When 5-FU was the only treatment alternative, patients generally stayed on treatment until their disease progressed or they developed unacceptable toxicity. This typically meant that patients were treated for four to six months (the median progression-free survival duration) and then were placed on supportive care alone until they died (median duration of survival approximately one year).",
"   </p>",
"   <p>",
"    Compared to 5-FU alone, newer combinations are more effective (median survival durations now consistently approach two years), but they are also more toxic. This is particularly true for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    -containing regimens, which cause cumulative neurotoxicity. Intermittent rather than continuous chemotherapy has the potential to reduce toxicity as well as cost.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H183911627\">",
"    <span class=\"h2\">",
"     Continuous versus intermittent",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whether continued chemotherapy provides better outcomes than intermittent therapy to best response followed by a chemotherapy \"holiday\" has been addressed in several trials [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H183911634\">",
"    <span class=\"h3\">",
"     Oxaliplatin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     Oxaliplatin",
"    </a>",
"    -based regimens (eg, FOLFOX) are increasingly used for first-line chemotherapy in mCRC. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/32/44554?source=see_link&amp;anchor=H29#H29\">",
"     \"Systemic chemotherapy for metastatic colorectal cancer: Completed clinical trials\", section on 'First-line oxaliplatin plus 5-FU/LV'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/45/10963?source=see_link\">",
"     \"Treatment protocols for colorectal cancer\"",
"    </a>",
"    .)However, oxaliplatin is associated with a cumulative sensory neuropathy which may be dose-limiting.",
"   </p>",
"   <p>",
"    Whether long-term neurotoxicity can by mitigated by intermittent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    -free intervals has been addressed in several trials, all of which are discussed in more detail elsewhere. The following represents an overview of the most important findings. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44058?source=see_link&amp;anchor=H9660072#H9660072\">",
"     \"Systemic chemotherapy for nonoperable metastatic colorectal cancer: Treatment recommendations\", section on 'Oxaliplatin-based regimens'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H183911641\">",
"    <span class=\"h4\">",
"     OPTIMOX trials",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most influential of these were the OPTIMOX trials:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The OPTIMOX1 trial randomly assigned 620 previously untreated patients to FOLFOX4, administered every two weeks until disease progression (arm A), or FOLFOX7 (",
"      <a class=\"graphic graphic_table graphicRef64504 \" href=\"UTD.htm?5/20/5454\">",
"       table 1",
"      </a>",
"      ) for six cycles only, followed by reintroduction of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"       oxaliplatin",
"      </a>",
"      at the time of progression after 12 cycles of a non-oxaliplatin-containing maintenance regimen [",
"      <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/12\">",
"       12",
"      </a>",
"      ]. The maintenance regimen consisted of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/54/24423?source=see_link\">",
"       leucovorin",
"      </a>",
"      400",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      over two hours on day 1 plus a 46-hour infusion of 5-FU 3000",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"       ,",
"      </span>",
"      every two weeks (arm B).",
"      <br/>",
"      <br/>",
"      Initial response rates were similar with FOLFOX4 and FOLFOX7, as was median survival (19.3 versus 21.2 month). Individuals in arm B had a significantly lower risk of developing grade 3 or 4 toxicity during cycles 6 to 18 (but not overall). The authors concluded that a survival benefit for maintenance non-oxaliplatin chemotherapy could have been masked by the large number of patients in this cohort (60 percent) who did not receive planned oxaliplatin reintroduction [",
"      <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The subsequent OPTIMOX-2 trial was initially designed as a 600 patient phase III trial, but when",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"       bevacizumab",
"      </a>",
"      became available, accrual was halted with 202 patients enrolled [",
"      <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/27\">",
"       27",
"      </a>",
"      ]. The primary endpoint was the duration of disease control, calculated as the sum of the duration of PFS both following the initial three-month of modified FOLFOX7 (mFOLFOX7) (",
"      <a class=\"graphic graphic_table graphicRef64504 \" href=\"UTD.htm?5/20/5454\">",
"       table 1",
"      </a>",
"      ) as well as after the subsequent reintroduction of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"       oxaliplatin",
"      </a>",
"      . An important characteristic of OPTIMOX-2 was that after induction of a response, metastases were allowed to progress back to baseline levels before FOLFOX was reintroduced.",
"      <br/>",
"      <br/>",
"      Complete discontinuation of therapy had an adverse impact on prognosis; the group receiving maintenance therapy had significantly longer median duration of disease control and median PFS from the time of randomization; there was also a trend toward improved median overall survival (24 versus 20 months, p = 0.42). These data mandate caution and both careful patient selection and vigilant patient monitoring so that therapy can be reinstated promptly at progression when considering chemotherapy-free intervals.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H183911673\">",
"    <span class=\"h4\">",
"     N016966",
"    </span>",
"    &nbsp;&mdash;&nbsp;The possibility that early discontinuation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"     bevacizumab",
"    </a>",
"    -containing therapy in patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    -based chemotherapy (ie, before disease progression) may compromise outcomes was suggested in the NO16966 trial, a randomized trial of two oxaliplatin-based regimens (XELOX and FOLFOX4, (",
"    <a class=\"graphic graphic_table graphicRef64504 \" href=\"UTD.htm?5/20/5454\">",
"     table 1",
"    </a>",
"    )) that was later modified to allow for further randomization to bevacizumab versus no bevacizumab [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/28\">",
"     28",
"    </a>",
"    ]. The addition of bevacizumab to either regimen significantly improved PFS; however, the magnitude of benefit was markedly lower than seen in other trials, and there was no impact on response rates. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/32/44554?source=see_link&amp;anchor=H46#H46\">",
"     \"Systemic chemotherapy for metastatic colorectal cancer: Completed clinical trials\", section on 'Oxaliplatin regimens'",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    Significantly more patients in the",
"    <span class=\"nowrap\">",
"     chemotherapy/bevacizumab",
"    </span>",
"    arms discontinued therapy for reasons other than disease progression, typically adverse effects. After reanalyzing the results according to whether patients were on- or off-treatment at the time of disease progression, the authors concluded that treatment continuation until disease progression was necessary to optimize benefit from the addition of bevacizumab.",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1632219\">",
"    <span class=\"h4\">",
"     MRC COIN trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;The inferiority of intermittent as compared to continuous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    and fluoropyrimidine-based first-line chemotherapy was also shown in the MRC COIN trial, in which 1630 patients were randomly assigned to continuous therapy until disease progression, toxicity or withdrawal of patient consent, versus 12 weeks of therapy followed by a chemotherapy-free interval until disease progression [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/29\">",
"     29",
"    </a>",
"    ]. The trial was powered for non-inferiority. Median survival was not significantly better in the continuous arm (19.6 versus 18 months; HR 1.087, 95% CI 0.986-1.198); however, the upper limit of the confidence interval exceeded the predefined non-inferiority boundary interval for survival (1.162).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H183911690\">",
"    <span class=\"h4\">",
"     CONcePT trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;A preliminary report of another multicenter trial, the CONcePT trial, in which patients were randomly assigned to continuous versus intermittent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    (alternating every eight cycles with and without oxaliplatin) also confirmed the benefit of intermittent rather than continuous oxaliplatin for increasing time on first-line therapy for",
"    <span class=\"nowrap\">",
"     oxaliplatin/",
"     <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"      bevacizumab",
"     </a>",
"     -based",
"    </span>",
"    combinations [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1632264\">",
"    <span class=\"h4\">",
"     XELOX and the MACRO and STOP and GO trials",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the Spanish MACRO trial, patients received six cycles of first-line XELOX plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"     bevacizumab",
"    </a>",
"    followed by a randomization to continued therapy or bevacizumab maintenance therapy alone until progression or treatment intolerance [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/31\">",
"     31",
"    </a>",
"    ]. There was no arm in which patients received no maintenance therapy. The median PFS and overall survival durations in patients treated with maintenance bevacizumab alone were not significantly worse, and rates of severe neurotoxicity, hand-foot syndrome, and fatigue were significantly lower. However, the trial failed to achieve its primary endpoint of non-inferiority within the projected upper limit of the 95% confidence interval.",
"   </p>",
"   <p>",
"    The Turkish STOP and GO trial design was similar to the MACRO trial but following six cycles of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"     bevacizumab",
"    </a>",
"    plus XELOX. A total of 123 patients were randomly assigned to continued therapy or maintenance therapy with bevacizumab plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"     capecitabine",
"    </a>",
"    (no",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    ) until progression [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/32\">",
"     32",
"    </a>",
"    ]. In a report presented at the 2012 annual meeting of the American Society of Clinical Oncology, the median PFS was significantly better in the group receiving maintenance therapy with bevacizumab plus capecitabine (11 versus 8.3 months), with less grade 3 or 4 diarrhea (3.3 versus 9.7 percent), hand foot syndrome (1.6 versus 3.2 percent), and neuropathy (3.3 versus 4.8 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1632309\">",
"    <span class=\"h3\">",
"     Irinotecan",
"    </span>",
"    &nbsp;&mdash;&nbsp;While intermittent treatment approaches appear to be almost mandatory for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    because of cumulative neurotoxicity, the advantage of intermittent treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/41/7834?source=see_link\">",
"     irinotecan",
"    </a>",
"    -based regimens is unclear. An Italian trial demonstrated that patients started on FOLFIRI (",
"    <a class=\"graphic graphic_table graphicRef76300 \" href=\"UTD.htm?19/2/19502\">",
"     table 2",
"    </a>",
"    )as first-line therapy had similar overall outcome (PFS and overall survival) whether or not the regimen was administered continuously until progression or toxicity, or in \"two months",
"    <span class=\"nowrap\">",
"     on/two",
"    </span>",
"    months off\" intervals [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/33\">",
"     33",
"    </a>",
"    ]. The mean chemotherapy-free period in the intermittent treatment group was three months. However, there were no demonstrable differences in treatment-related toxicity between the continuous versus intermittent treatment groups. Of note, further second- and third-line therapy did not follow a \"stop-and-go\" approach, so that for overall survival, any potential differences obtained in first-line therapy could have been obscured by subsequent treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44058?source=see_link&amp;anchor=H21#H21\">",
"     \"Systemic chemotherapy for nonoperable metastatic colorectal cancer: Treatment recommendations\", section on 'Irinotecan-based regimens'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H183911700\">",
"    <span class=\"h3\">",
"     Summary",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal duration of chemotherapy remains unclear. Data from the OPTIMOX2, MRC COIN, and NO16966 trials suggest that a complete stop of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    -based therapy can be associated with an inferior outcome and thus should not be the default strategy.",
"   </p>",
"   <p>",
"    On the other hand, it is reasonable to discontinue",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    alone if clinically significant neuropathy develops and to switch to a non-oxaliplatin-based regimen to permit as much recovery as possible before reintroducing oxaliplatin. Nonoxaliplatin maintenance chemotherapy with a fluoropyrimidine with or without",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"     bevacizumab",
"    </a>",
"    could also be pursued after a fixed number of cycles before the onset of severe neurotoxicity as a means of preventing its development. Since the incidence of grade 3 neurotoxicity rapidly increases after a cumulative oxaliplatin-dose of 640",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/34\">",
"     34",
"    </a>",
"    ], clinicians should be particularly attentive to symptoms of increasing sensory neuropathy after four months of therapy containing 85",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    oxaliplatin every two weeks. Treatment continuation is also an option, particularly if chemotherapy is well tolerated and if disease is aggressive",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bulky. Some patients have excellent tolerance of the drug for many months or even years.",
"   </p>",
"   <p>",
"    The benefits of intermittent treatment are even less clear for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/41/7834?source=see_link\">",
"     irinotecan",
"    </a>",
"    -based regimens.",
"   </p>",
"   <p>",
"    In general, the decision to permit treatment breaks during therapy must be individualized and based upon several factors, including tolerance of and response to chemotherapy, disease bulk and location and symptomatology. As an example, there are many patients with small volume but multiple sites of disease who respond to chemotherapy or have a prolonged period of disease stability. Even if their disease triples in volume off therapy, they will not likely be symptomatic or develop organ dysfunction. This is in distinction to those patients with retained primary tumors, bulky disease, poor performance scores due to tumor related symptoms or those with peritoneal disease that may lead to unsalvageable bowel obstruction as the first sign of progression. Patients with favorable characteristics may be able to tolerate chemotherapy-free intervals of multiple months per year and go on to respond favorably to drugs for many years. On the other end of the spectrum are patients with extensive symptomatic disease who progress through treatment regimens in quick succession with either short lived responses or no response; they must be managed quite differently. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44058?source=see_link&amp;anchor=H17#H17\">",
"     \"Systemic chemotherapy for nonoperable metastatic colorectal cancer: Treatment recommendations\", section on 'Reducing drug toxicity with chemotherapy holidays'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H183911707\">",
"    <span class=\"h1\">",
"     ASSESSMENT DURING THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Response is typically assessed using interval radiographic evaluation (typically every two to three cycles) and by periodic assay (every one to three months) of serum carcinoembryonic antigen (CEA) levels. Radiographic tumor response is usually quantified using RECIST (Response Evaluation Criteria In Solid Tumors) (",
"    <a class=\"graphic graphic_table graphicRef74693 \" href=\"UTD.htm?41/48/42764\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Persistently rising CEA levels (particularly rapidly rising levels [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/37\">",
"     37",
"    </a>",
"    ]) are highly correlated with disease progression [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. However, 2006 guidelines from ASCO suggest confirmatory radiologic studies in this setting prior to a change in therapeutic strategy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/40\">",
"     40",
"    </a>",
"    ]. Caution should be used when interpreting a rising CEA level during the first four to six weeks of a new therapy, since spurious early elevation in serum CEA may occur, especially after",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/41-43\">",
"     41-43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/27/19890?source=see_link\">",
"       \"Patient information: Colon and rectal cancer (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?6/0/6148?source=see_link\">",
"       \"Patient information: Colon and rectal cancer (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?39/22/40293?source=see_link\">",
"       \"Patient information: Colorectal cancer treatment; metastatic cancer (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9659249\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The median overall survival for patients with unresectable mCRC who receive best supportive care (BSC) alone is approximately five to six months. Systemic chemotherapy produces meaningful improvements in survival that are most pronounced in patients who are exposed to all active drugs, including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/41/7834?source=see_link\">",
"     irinotecan",
"    </a>",
"    , fluoropyrimidines, therapies targeting angiogenesis (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"     bevacizumab",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/28/37312?source=see_link\">",
"     aflibercept",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32006?source=see_link\">",
"     regorafenib",
"    </a>",
"    ), and therapies that target the epidermal growth factor receptor (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/58/10151?source=see_link\">",
"     cetuximab",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/48/6918?source=see_link\">",
"     panitumumab",
"    </a>",
"    ). Although no trial has compared any of these regimens to BSC alone, median survivals now far exceed five to six months, going beyond two years. (See",
"    <a class=\"local\" href=\"#H183911606\">",
"     'Chemotherapy versus supportive care'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9659590\">",
"    <span class=\"h2\">",
"     Goals of therapy",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Goals of chemotherapy for metastatic colorectal cancer (mCRC) differ according to the clinical scenario. For most patients, treatment will be palliative and not curative, and the treatment goals are to prolong overall survival and maintain quality of life (QOL) for as long as possible.",
"     </li>",
"     <li>",
"      However, some patients with stage IV disease (particularly those with liver-limited metastases) can be surgically cured of their disease. In such cases, the key parameter for selecting a specific regimen is not survival or improved QOL, but instead, response rate (ie, the ability of the regimen to shrink metastases). Even selected patients with initially unresectable liver metastases may become eligible for resection if the response to chemotherapy is sufficient. (See",
"      <a class=\"local\" href=\"#H9654617\">",
"       'Treatment goals'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9659440\">",
"    <span class=\"h2\">",
"     Timing and duration",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although data are limited, for patients with categorically unresectable mCRC, we suggest instituting chemotherapy at diagnosis, and when possible, before patients become symptomatic (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H183911613\">",
"       'Timing of chemotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The optimal duration of initial chemotherapy for unresectable disease that does not progress is controversial. In general, the decision to permit treatment breaks during therapy must be individualized, and based upon several factors, including tolerance of and response to chemotherapy, disease bulk and location, and symptomatology. (See",
"      <a class=\"local\" href=\"#H183911700\">",
"       'Summary'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9659454\">",
"    <span class=\"h3\">",
"     Oxaliplatin-based initial therapy",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients who are responding to an",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"       oxaliplatin",
"      </a>",
"      -based initial regimen, we suggest discontinuing oxaliplatin before the onset of severe neurotoxicity (usually after three to four months of therapy) and maintaining the fluoropyrimidine backbone, with reintroduction of oxaliplatin at disease progression (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Another acceptable alternative is to switch to an",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/41/7834?source=see_link\">",
"       irinotecan",
"      </a>",
"      -based regimen. Continuation of treatment is another alternative in responding patients who have no clinically significant neuropathy. (See",
"      <a class=\"local\" href=\"#H183911613\">",
"       'Timing of chemotherapy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/45/10963?source=see_link\">",
"       \"Treatment protocols for colorectal cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In such patients, we suggest not pursuing a full break in therapy as the default strategy in patients who achieve a partial response or stable disease, because of the potential adverse impact on outcomes (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). If a treatment break is negotiated because of toxicity or patient preference, patients should be informed as to the possibility that survival may be adversely impacted. In such cases, close follow-up with tumor assessment at two month intervals and early resumption of chemotherapy at the first sign of progression is recommended.",
"      <br/>",
"      <br/>",
"      On the other hand, if a clinical complete response is achieved, a complete break in therapy is reasonable since at least some data suggest that continued treatment beyond two cycles after confirmation of the complete response is not associated with better survival than watchful observation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44058?source=see_link&amp;anchor=H18#H18\">",
"       \"Systemic chemotherapy for nonoperable metastatic colorectal cancer: Treatment recommendations\", section on 'Definitions'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9659798\">",
"    <span class=\"h3\">",
"     Irinotecan-based initial therapy",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      While intermittent treatment approaches appear to be almost mandatory for",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"       oxaliplatin",
"      </a>",
"      because of cumulative neurotoxicity, the advantage of intermittent treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/41/7834?source=see_link\">",
"       irinotecan",
"      </a>",
"      -based regimens is unclear.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9659831\">",
"    <span class=\"h2\">",
"     Response assessment",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      During chemotherapy, response is typically assessed using interval radiographic evaluation (typically every 8 to 12 weeks) and by periodic assay (every one to three months) of serum carcinoembryonic antigen (CEA) levels. Persistently rising CEA levels are highly correlated with disease progression. However, 2006 guidelines from ASCO suggest confirmatory radiologic confirmatory studies in this setting prior to a change in therapeutic strategy [",
"      <a class=\"abstract\" href=\"UTD.htm?21/20/21833/abstract/40\">",
"       40",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H183911707\">",
"       'Assessment during therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/1\">",
"      Weeks JC, Catalano PJ, Cronin A, et al. Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med 2012; 367:1616.",
"     </a>",
"    </li>",
"    <li>",
"     Petrelli NJ. Plenary program discussion. 43rd annual meeting of the American Society of Clinical Oncology, Chicago, Illinois, June 4, 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/3\">",
"      Folprecht G, Grothey A, Alberts S, et al. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 2005; 16:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/4\">",
"      Grothey A, Hedrick EE, Mass RD, et al. Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107. J Clin Oncol 2008; 26:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/5\">",
"      Siena S, Peeters M, Van Cutsem E, et al. Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab. Br J Cancer 2007; 97:1469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/6\">",
"      Giessen C, Laubender RP, Ankerst DP, et al. Progression-free survival as a surrogate endpoint for median overall survival in metastatic colorectal cancer: literature-based analysis from 50 randomized first-line trials. Clin Cancer Res 2013; 19:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/7\">",
"      Grothey A, Sargent D, Goldberg RM, Schmoll HJ. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 2004; 22:1209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/8\">",
"      Grothey A, Sargent D. Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line. J Clin Oncol 2005; 23:9441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/9\">",
"      Tang PA, Bentzen SM, Chen EX, Siu LL. Surrogate end points for median overall survival in metastatic colorectal cancer: literature-based analysis from 39 randomized controlled trials of first-line chemotherapy. J Clin Oncol 2007; 25:4562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/10\">",
"      Buyse M, Burzykowski T, Carroll K, et al. Progression-free survival is a surrogate for survival in advanced colorectal cancer. J Clin Oncol 2007; 25:5218.",
"     </a>",
"    </li>",
"    <li>",
"     Eng C, Maurel J, Scheithauer W, et al. Impact on quality of life of adding cetuximab to irinotecan in patients who have failed prior oxaliplatin-based therapy: the EPIC trial (abstract). J Clin Oncol 2007; 25:164s.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/12\">",
"      Tournigand C, Cervantes A, Figer A, et al. OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study. J Clin Oncol 2006; 24:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/13\">",
"      Allegra C, Blanke C, Buyse M, et al. End points in advanced colon cancer clinical trials: a review and proposal. J Clin Oncol 2007; 25:3572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/14\">",
"      Goldberg RM, Rothenberg ML, Van Cutsem E, et al. The continuum of care: a paradigm for the management of metastatic colorectal cancer. Oncologist 2007; 12:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/15\">",
"      Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol 1992; 10:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/16\">",
"      Scheithauer W, Rosen H, Kornek GV, et al. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 1993; 306:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/17\">",
"      Simmonds PC. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ 2000; 321:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/18\">",
"      Sanoff HK, Sargent DJ, Campbell ME, et al. Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741. J Clin Oncol 2008; 26:5721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/19\">",
"      Renouf DJ, Lim HJ, Speers C, et al. Survival for metastatic colorectal cancer in the bevacizumab era: a population-based analysis. Clin Colorectal Cancer 2011; 10:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/20\">",
"      Hobday TJ, Cha S, Buroker T, et al. Long term survivors (LTS) of metastatic colorectal cancer (MCRC) treated with chemotherapy only: A North Central Cancer Treatment Group (NCCTG) review (abstract). Proc Am Soc Clin Oncol 2002; 21: 174a.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/21\">",
"      Ackland SP, Jones M, Tu D, et al. A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer. Br J Cancer 2005; 93:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/22\">",
"      Voskoboynik M, Bae S, Ananda S, et al. An initial watch and wait approach is a valid strategy for selected patients with newly diagnosed metastatic colorectal cancer. Ann Oncol 2012; 23:2633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/23\">",
"      Chambers P, Daniels SH, Thompson LC, Stephens RJ. Chemotherapy dose reductions in obese patients with colorectal cancer. Ann Oncol 2012; 23:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/24\">",
"      Griggs JJ, Mangu PB, Anderson H, et al. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2012; 30:1553.",
"     </a>",
"    </li>",
"    <li>",
"     Labianca R, Floriani I, Cortesi E, et al. Alternating versus continuous FOLFIRI in advanced colorectal cancer (ACC): a randomized GISCAD trial (abstract). J Clin Oncol 2006; 24:147s.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/26\">",
"      de Gramont A, Buyse M, Abrahantes JC, et al. Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancer. J Clin Oncol 2007; 25:3224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/27\">",
"      Chibaudel B, Maindrault-Goebel F, Lledo G, et al. Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 Study. J Clin Oncol 2009; 27:5727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/28\">",
"      Saltz LB, Clarke S, D&iacute;az-Rubio E, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 2008; 26:2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/29\">",
"      Adams RA, Meade AM, Seymour MT, et al. Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet Oncol 2011; 12:642.",
"     </a>",
"    </li>",
"    <li>",
"     Grothey A, Hart LL, Rowland KM, et al. Intermittent oxaliplatin administration and time to treatment failure in metastatic colorectal cancer: Final results of the phase III CONcePT trial (abstract). J Clin Oncol 2008; 26:180s.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/31\">",
"      D&iacute;az-Rubio E, G&oacute;mez-Espa&ntilde;a A, Massut&iacute; B, et al. First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study. Oncologist 2012; 17:15.",
"     </a>",
"    </li>",
"    <li>",
"     Yalcin S, Uslu R, Dane F, et al. Bevacizumab (BEV) plus capecitabine as maintenance therapy after initial treatment with BEV plus XELOX in previously untreated patients with metastatic colorectal cancer : mature data from STOP and GO, a phase III, randomized, multicenter study. J Clin Oncol 30, 2010 (suppl; abstr 3565). Abstract available online at file://www.asco.org/ASCOv2/Meetings/Abstracts?&amp;vmview=abst_detail_view&amp;confID=114&amp;abstractID=96665 (Accessed on June 19, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/33\">",
"      Labianca R, Sobrero A, Isa L, et al. Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised 'GISCAD' trial. Ann Oncol 2011; 22:1236.",
"     </a>",
"    </li>",
"    <li>",
"     Green E, Sargent DJ, Goldberg RM, Grothey A. Detailed analysis of oxaliplatin-associated neurotoxicity in Intergroup trial N9741 (abstract). Data presented at the 2005 ASCO Gastrointestinal Cancers Symposium, Hollywood Florida, January 28, 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/35\">",
"      Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/36\">",
"      Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/37\">",
"      Iwanicki-Caron I, Di Fiore F, Roque I, et al. Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancer. J Clin Oncol 2008; 26:3681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/38\">",
"      Shani A, O'Connell MJ, Moertel CG, et al. Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinoma. Ann Intern Med 1978; 88:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/39\">",
"      Trillet-Lenoir V, Chapuis F, Touzet S, et al. Any clinical benefit from the use of oncofoetal markers in the management of chemotherapy for patients with metastatic colorectal carcinomas? Clin Oncol (R Coll Radiol) 2004; 16:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/40\">",
"      Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006; 24:5313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/41\">",
"      S&oslash;rbye H, Dahl O. Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to oxaliplatin combination chemotherapy: implications for tumor marker monitoring and guidelines. J Clin Oncol 2003; 21:4466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/42\">",
"      Ailawadhi S, Sunga A, Rajput A, et al. Chemotherapy-induced carcinoembryonic antigen surge in patients with metastatic colorectal cancer. Oncology 2006; 70:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/20/21833/abstract/43\">",
"      Strimpakos AS, Cunningham D, Mikropoulos C, et al. The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy. Ann Oncol 2010; 21:1013.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15802 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-A7B94B43F3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_20_21833=[""].join("\n");
var outline_f21_20_21833=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H9659249\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H183911197\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7582384\">",
"      CHEMOTHERAPY OPTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9654617\">",
"      TREATMENT GOALS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9654802\">",
"      Potentially resectable disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9654809\">",
"      Nonresectable disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H183911606\">",
"      CHEMOTHERAPY VERSUS SUPPORTIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H183911613\">",
"      TIMING OF CHEMOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23214887\">",
"      CHEMOTHERAPY DOSING IN OBESE PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H183911620\">",
"      DURATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H183911627\">",
"      Continuous versus intermittent",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H183911634\">",
"      - Oxaliplatin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H183911641\">",
"      OPTIMOX trials",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H183911673\">",
"      N016966",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1632219\">",
"      MRC COIN trial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H183911690\">",
"      CONcePT trial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1632264\">",
"      XELOX and the MACRO and STOP and GO trials",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1632309\">",
"      - Irinotecan",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H183911700\">",
"      - Summary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H183911707\">",
"      ASSESSMENT DURING THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9659249\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9659590\">",
"      Goals of therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9659440\">",
"      Timing and duration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9659454\">",
"      - Oxaliplatin-based initial therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9659798\">",
"      - Irinotecan-based initial therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9659831\">",
"      Response assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/15802\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/15802|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/20/5454\" title=\"table 1\">",
"      Chemo regimens met CRC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/2/19502\" title=\"table 2\">",
"      FOLFIRI regimen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/48/42764\" title=\"table 3\">",
"      RECIST response criteria solid tumors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=related_link\">",
"      Management of potentially resectable colorectal cancer liver metastases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?6/0/6148?source=related_link\">",
"      Patient information: Colon and rectal cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/27/19890?source=related_link\">",
"      Patient information: Colon and rectal cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/22/40293?source=related_link\">",
"      Patient information: Colorectal cancer treatment; metastatic cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13834?source=related_link\">",
"      Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13560?source=related_link\">",
"      Surgical resection of pulmonary metastases: Outcomes by histology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/32/44554?source=related_link\">",
"      Systemic chemotherapy for metastatic colorectal cancer: Completed clinical trials",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44058?source=related_link\">",
"      Systemic chemotherapy for nonoperable metastatic colorectal cancer: Treatment recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/45/10963?source=related_link\">",
"      Treatment protocols for colorectal cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_20_21834="Gram stain sputum 12A answer";
var content_f21_20_21834=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F56469%7EID%2F64064%7EID%2F75864%7EID%2F54937%7EID%2F66696&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F56469%7EID%2F64064%7EID%2F75864%7EID%2F54937%7EID%2F66696&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aspergillus fumigatus in sputum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 366px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gram stain of sputum (x1000) shows inflammatory cells and poorly- staining, large, septate hyphae which tend to branch at acute angles. Filamentous fungi are usually better seen by wet mount or silver stain. Aspergillus fumigatus grew from this specimen on Sabouraud's agar.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aspergillus fumigatus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 361px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Swartz-Lamkin's wet mount of the same sputum (x1000) shows uniform septate hyphae which branch at 45&ordm;. Aspergillus fumigatus grew from this specimen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aspergillus fumigatus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 366px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Silver-stain of lung tissue (x400) shows septate hyphae with acute angle branching characteristic of Aspergillus fumigatus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aspergillus fumigatus on Sabouraud's agar",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 345px; height: 240px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADwAVkDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5VPNFKME8nApKBhS0lLQAox36UACkq3bxBV8yQcdgaTdikrhFCEXe/XsKlCjIJALdlxSAnIJGWP3V/rWzpOmmTdLO5jQDLyYzj/ZHq38qynNRV2axjfREem6W0pMkmFCEb3YZVM/zPtV2e4ijjaC1QBCclj1c+p/w6CkvbsOBHAoihXgIv889z71S/GsLOTvItu2kR+BnJ605SAe1MXrg0ucDrVMlDy3pTc5ppPFN3flSsMfnnJo600U4Y7UDQ6nAYH9aaDinikMVOvvT/wCdIvYjmnqvUGkOwgFPX3pQtKBz0pXKsGO1A56U7mlA6Y70riDtT1HHfFIBTulJgKVBXgUm0fUUoOAc0vUZxQA0A5PFKV4BFL6cZpwFFwIxkHoKuWrRuwVjgntVZunFNxhsjND1EnY6CJUBVZMmPPDj7ye4pup6Ut2okUqJ2+7IOFl+voapWd2cbXP51q28/lAnAeI/eQ/zHoa5pKUXdGqaZzRVo3MM6lJhwQaapMJ2uu6A9Qf4fpXVanp8V/bqysC4HyTY6f7LVzLo8btDOpVl45HWtqdRTRMomXqVj5QEsPzQnuO1Zq56YrpIswfK43QMeQecVn6pZC1BljG6JucjtXTGfRmUo9TLjIbdjJIODTs9vXmi1QrGN4AYkkipigwKtshIhbg8Dml5P41N5HBYHNRd8Gi4WsU9ROYPoelZdamo8W/4isutobGU9xaKKKokWikqWCJppQijJNA0T2Nv5zF3/wBWnWrEjbhvPMecIPWp51VQtvF9yMZkarGmWEl1PGyx7mbiNPp3PsKxlNL3mbRj0Q/SNOaZy8h2kDczkfcH+PoKt6hdjAggBWBMhVP8z7mruqSR2duLW3YlB8zMerse/wDnt9awWYkkn1rCN5vnZcny+6h2ehNLuqLPNG6tCCTdRu/Oo80ucUDHbutGcio9xPSl7896VgJN2Oppy01AWPHNaNnps05ztOO9TKSjuXFN7FRQSasxQu3RSa6nTfDQdQzZyO1dJbeH4kUNtxg4PNcNXHQhsdEMPJ7nn8OnTuu4JxVqPRLrj5etejxadCoK7R7e9TxW6PtAH046VxyzJ9EdEcKjzseH7g08eHrjOQBzXpq23zn93yR6U6K1QyBSvGMVg8ymX9VieWSaJcqx+XOKrPp0yDlCK9eNogDbk6HpUFxpcUnQDmqjmb6ol4VdDyJoWXJIIqMKccda9LvPDccpO0HFc7e+HZYWbYCQK7KWNp1OphOhKJy23t1p/HT9KvTWE0LHchA9aqOhDDjgV1qSlsYtNEQNKDzTse1BXmnckBTSCDT1Xp3p5Ax0+tFwsQ8qPerlnckHaxNVmFGMDI/Om7NWYbHR2dwYmLL80bcMnrT9W06O8t0lQ84/dP6f7JrGsLgqQrV0FjcKmQwDQuMOP6j3rkmnB3RrFo5LJBaOZcEcEEUR7Rm2n+aCQ/KT2rofEGmt/rY/mkC5BH8a+v1Fc6oEqFH/AA9q6Kc1NXFKNmZN9aNaXTRuPlP3TUGAzn0rfEYvLc20vE8YyreorAkUxylX4YcHNdMJX0ZjJWLNoh6Hoahv4DDKTjg1LasVIJ9c1dvYxPb+pFF7SKteJzOpYNuD3zWVWrqIxbkHsRWVXTDY5J7i0tJS1ZIV0Ftb/wBnWPmOn+lP90HqM/4VU8PWpnvlkKh1iIbDdCewPtV6+uDe3kk6jksUiUfqaxnK7sbQjZXIbWAzMY+QifNK/wDePpXW6fAtnZtNIdk0iZOePLj7D8ep/D1qHRtNjij8yTHk24Dvn/lpJ2WofEt2ygWrZ85j5k5PXcei/gP1+lcc5e1lyr+v6/yN0uRXZjX1ybictjC9AKqk0jNxTc11JW0MGx1HvmmZyOaTNMCQn06UmaaOhyeaOpxSGOHXir1rZyTEYBxUuk6c9xMowcE16FpOjrGqDHRfxBrkxGKjS06nRSouerMTStCVQDIM5GeldRZafFEqJgHI4Pp9atwQbSBtx7VtWForgNgZHUe9eLWxMp7s9CNOMEV7C0b7oQ/UeldRomifaCu8Z9eKl0y3UAK3GTjNdZpcQikzkADH0NcM5XLT7HEeLdNXSvJdRhXJ49DWfpyK5V2Hyt1HpXSfF11+wQMnVTXIaHd7rZcjrinFXhctN2OtsrBZ3Ufwnrx1pZoYhe+WUC9vTNWtMvFig5Az71zN3qLPrBYnoeKztdiVzoxpkTz8jOe1NbSA8u0AAHNFnebstk5PA9q1rW8i29QWHc1LQczOcudLlgG9BuAODxWbPbrvIkj+9XoESrIDyGU+lMl0eOdgccYwBSs1sPmvueZ3ukQywsxVenAx1rldU8N45RcH6V6vruki1AIOF9Caw3i34Djj1rSli50nuKVGM0eN3mny27nehx9Kpbeelev6lpEdzGflritX0F4csq4Ar2cPj41dHoziq4dx1Ry2fkxjmjOCB1qeSFomIfrVY45xXenc52BPFIuduOaUqO3WnhcHj0qiRi5zkcVr6dc5+RqyuCMnrUkLlHDDoOtTOPMrDTsdnZsJ4/sjkZPMbk8g+n41y+tWRs7nzVUhGYh1xja1a9hJ5yAHqO9aeowrfae0uDuUbJx6js3+fT3rjjJ05myd1Y4edW+WWL/WJzn1FVtZtlniS8h6EYcehq7Kr2c5hkx8p6+oNOs8RTtbuAYJ+mfWu+LtqjKRzqcFa0LdgQQTUN5am3ungbIweM9xUUJaPIatX7y0EtCr4jtglqZE+7kVzFdhr5D6M5/2l/nXH1vRd46nNXVpaC0qglgAMk9qStXwzaG81aFQMqh3n8On64rSUuVNsziruxszW7aVpUNqBtvJ+HGMEZ6/0FS6BZ/aboSRoWSI+WgHU+ppNWL3Wq3M0ZLhWEEbHu38R/n+ddFoNgLGfzsDyrOPeSehkPA/x/CuCrU5YX6s7IRvLyL+rSQ2MWxAqpaDcQf+Wkp6D8MfofWvPbuV5Znkkcs7HLMT1NdD4oueUgyd4zJKT3dv8BgfXNcrK3NGFp8sbsmtK7EZqTNMJyKd25rrMRS2aaSegzSsAfu5pue1AxwNael2bTzDCk/hVOzt2mkUAZJr0Lw9p8cUatnL9cVy4muqUTejSc2X9I0yOOBSoG7jt1rutC0cXUgIO0MOTWJpdq27cfu5zjFd3oKqjfKoB2185XqOT3PTS5VoZGu6NLZRrMqZQcEisy2uBA24tx6V6nItvd2DQsqkkY5FeQ+JrObSr9woPklvyrKm+Z8pS13Oysb1Gjj2/gK3NPnfzQGY4PIz2rz3RLxeFb0BruNPuI5GUg+1Z1FZ2C1il8THVtOUnng1xHhmXeyYHyntXY+O3MmlyYwTtOOK888JzlJdrtkg/wA62pRvSbHzW0PTLyHydP8AN4I9cVx5YtfFuxrqmuHOiTA5cgciuJtptty275eeKzhF6jjI7m2QLbRkntUY8yMELk89fSm6beK6InXAret7WKWPcMYbrWT0FcqaNdyI2CciuottQihgMkzKoHXNYX2VLSbcSNtcT4u11pJvs9tIQvQ4oinN2RVrmprWuHVdVZYW/co2ODwa07a1EsC5HNcZpSbCmOp5PvXaaNcDayue3FKUUXK8diCeyZMunAz90c1j3lqk4KEDPfNd0kYliIOAG9KxNR09VLMvynPBxWdnF3RKfNozyzX9ECgsi559K467tWiYgqcV7RPaq6BWA3EcVxviHRyNzIBivWweN+zI5K1HqjgWXA+lLzn1qxdwmFyCOnSqx9a9lO5xPQQ9eaFOGHXAPSkIyRQeKsRp6bOY3A9OQPauq024CSBm/wBU42yAd1PX/PtXFW74xx8wrodMm3LsPTqK5MRDqaQZX8V6f5Er7fm8vGHXoyHof8+tYIUy25UE+YnINd/dIl1pQbaTJb/I/wDtRn/A5H5VwciNZ3xV+QpwfcVeHm5R5eqCa6i6kn2ywju0H7yPhx39/wDH8ayiAeGx61uWaql1Lbt/q5wdv5f4Vh3MRtrmSFz8yHH1rpg+hBQ1r/kFyjtlcfnXLV1WuDGmSDvx/OuVrso/Cc1f4hfpXf8AgbSZF0K/1IryRiP3PRf1P6VwSKXYKoyScAV9DeGtNisrfw/p0uNiqbycEdUjH9TurkzCv7OCS6/pqa4WnzNt9DmdP8PGyvrOxn/1sSBnU/32wf6gfhW/r1imkQJHcL8rZupV/vADgfT7o/4FWz4KhGt+JJNRuwMXM5ZSe3PH4Vj/ABn1SNtQuYoSpLlY8r2Vecfqo/4DXke1lVrKm/md/s1GLkeSapctPcySOcu7Fm+prLZsk1Zu2wxJPtVPOa+ggrI8yTuxQaCeKTNNqhD165qSJN71EByK19HtGnmUKucc/WpnJRVyoR5nY6DwxpIcea/A9DXb2kSl12JxntWZpkSwwKMEHoQf511ejWwIBwAD2xXzuJrOcm2evTgoRNbQrIPlSPTmtu8Y2EQYYyKt6TaKkAYAKegz3rM8Tlmtm25yD3rzXK8rF77mhp2oCRQQT1zRrltFqVi+5Mvg4wOtcZp160IKhuT+lbkeq+QmXY4HvxTcGnoGxxEqyadeiOQbVz8v+Fdf4cvg2GaQDByAap+KLeHVNPNxakeYozgCuO0HVWglEcpOVyTz0rpVP2sL9UQ5noniWbfaSjr8przfSn8rUGwMKa7KW8+1WTgsMEHB/CvP2lK3DIpw6E8ZrXDU/dcSHPU9U0+8821aIEEkVzWqRPBd5A+U9c9Kh0DUGjj3PINxHFalw5vLfO3Lj1rF03CQKZc8PyhinByetdrc3kWn6cJGPJHNcR4fgeBgW4UDJz2qh8Q/EyRwR2yEeZ0wDWXsXUnyxL9pYs+JPGOY9sPc4GKx9Ije7xJLyTkiuU01WvrvdksvHFeg6XCLeNFIwScD2rarSjRjyrcuE76mnp9gWbI/h5rUtozG/wA2QKXS/vheM5Ga1ruOJVYg1wN6mnNclsbobgrnAPFS6ndRCIgkE9h61x9/qTRttRjuFNsZ5JpczMTn36UmhqL3Ne4tllXzFGBjNZl7aiaEqwGfSupgiVrdSoznqB2rM1S1MbllU+uB6VFuV3QX5keP+JdPMUzkA7cmuYdcEivWPENgtxCxC4wCTXmt/bmGZhg19Dgq/tIWZ51anyszuhxzSdc5HGakYfXNMY4HIzXoI5whbawrZ0+Uo4AJwD+lYYGDWhZOflJPSpqRuiond6PKiTqJMGCYeVJ9D3/Dg/hXKeKtPkhk3MvMTGF/bHT+v5VuaW2+HBPI4q74qg+3WiTouGuIcMPWROv54z/wKvPpy9nUNmrxOCVi1tFMv34GB/CofFMCiWG8hyY51A/GrOm4MssDDiQEc+tTy2xvPDc9v/y2tXJx3x1/lmvRvyyMdzi9YbOnSD6fzrma39V3LZuD04/nWBXoUlZHJW3NzwZaC88S2MbAFQ+9gfRRn+lei6nrV1Dd6vJzmSCPTrc/3VJ+cj8m/OsL4Lacl54jlmmA8qKPDE9s8n9Aa7HxDpZa30UIgM1/O82B6AgD9c15eKqxeI5ZdF/wf0O3Dwfs011/4Y7z4f2MdvZwXTlRHbQM/J6H7o/mTXjnji68/VG3Nkqu5v8AeYlm/U4r2z+yLjRfh4PPDLPcuIyD2BJH8mP5V8763MZrueT++5P61w5dTUqsql7nRXqPksY122SB+dVc4p87Zc1ETX0KWh5bHtlc5pqn5ueKYT2py9aqwFiFC7geldz4XsCESQjqc5HauS02MMnI5ZsA16h4etwloiqSema83H1eWNkdmFhd3Zes7fdIOgYcZrrtMtyrIQMY4OKr6ZpcknVeB+FbSWjRAuRgivnp1LnoPsaNncBdqKR8vrRrdutxbMVI98Vgvc7XJIww6VIupK64kfDVg03qgtY5G9mNnebf4c+lY+u65I8scETEKeSRW54u2SWbyRdcZrzi2la53CY4IOBXrYWkprnfQynLoeiaVqe22MbEEY6+1c1qUYh1N5IcfNz696pac0j3JQswUc5zV5QZpsSDGBnIrWNNU5NmLlc37S4/0QKSfu+lYHkE3skjjr8v0q9auYCQHOwfwmoA0bSytLIEX7wJPepj7t7CtcuC2aMBQeAAa6HRiVgHm5x1Feep4qh/taOGNt0Y+UtXZW2qRiIsTwB3qK9OaSTQJp6ov69rqadbSsOAATivIr3UJNT1PznctvbOfSpvGOu/bdQ+zRkCPsfes7R4/Luhv+Ykgcd67sNh1ShzPdmUpOUrHoPhaGMMOTn6V3c0LRJHLnI6fjXLeGkVAmARkflXXtM4tgMYTvmvKxPvTOiMrFixuxEgYtg/Xmm3+s74vLhJJJ54rktWu5omJVe/H0o06cyjdnB6GueVCy5mdEJ3NRA8soLc1oW4MRBLEZqK1kjxkkE1O5LHC1zyOhPodXoN0Hj2t8xFX7q389HIxu7fSuU0qdoZF5xj0rsoJRLCAD14qdzN+6zjr+FQ0iEZHQV594o00gtIq/pXrGq22GJUDGK5TW4Vnt2UCtMNVdKaJqw5onj8ke0EHqelRYrU1S2MMr4zx/KsxunFfTQlzK55jViM4qxbN71WIPPoKdEfm61o1dCR12hTcgH0rrWCy6FcoAfNt5FnQ/7J+Vv1CVwWiS7ZEr0XR4vPlMI/5bQvHj1O3K/qoryMSuSdzpp6o8tvUFnrLgfdWTI+h5FaulRga5cQ4zHcQlgD6j/62ai8ZW4juLeUdXTafqpx/LFMWYxvpV4OMOqk+x4rvT54p90YtWbOG8QReVb3Mbj5422/ka5SvQviVbra6heKAf3iq/8Aj+orz2vTw75oXOOv8R7D8HIBF4X129x821lU/wDAQP8A2evS4LVLjxp4dtMAizs4yRjoSN5riPhfblPhheSDjzrhV+uZF/8Aia9J8KRef8StYcDP2WIRD2woX+tfM46d51Jev6L9T1sOrRivI6D4sTC18LQLnAXdIPwRgP1K18m3fU56mvp349z+XoUMIOCIjn8WT/69fL9+flcj3rqyeP7tvzMsS9EYshyxplKxyabnjivoDzgpwpop8fzOo7k4oYHTWES+fZwgY2oC3Hc816ZpACmIEZ44xxXnmhfvdTd+oBxg+gr0rRUSSVWBIAI4rwcwlrY9PCr3bnofhqZRGEkQc9Qeta2pWsLqfJwuRWDpe6PkcgevWrVzdFmOMivEkjovqZWoaZJ1Rj9MVzF+Jrd8ENjPWuwnviMKTntVSdYLoHzVU/hVwfK9Qb0PONeupTZuo3ZIxj0riom27ueSecmvWNc0pViZo8Yx0rzjVdIk8x2Q7c98dDXs4OpFxsctVu9zQ0BlO7OCeh55qXVkvLOJpbcecn91RzWPYrPZAmQB8Dlh1Nbuk6+bqR4nhxgYORV1ItS5o6ohPQ5648QtGMIB5+MbC33fbFPt0lvYDNeOz5HKZ7/SsPWLdT4nlMQGGbdgdjXWWCLDCDLgqQBnoc10VFGEU47siLbbuc9B5N1evbRxLDIhysmORS3mr3Fmj20m9SOMnv7isvU2m03XZGLbgTkHsRWrNfQ6lbbZkVjjjNauOzauiL3uupzBkLuJmfJ/Wt3RpfNmhzwVI5z1qu2jKY3ktXUsB/qy2ag02UwsyhSsqHkHsa2k1OLsTG8Xqeu2N6sEMe0Akj1ro9Pu2nVRy+fWvO9BvhJGPMY7sYrqNOlkhXK5BJz9K8OtS5WdN77G3qVqk8bgjBWuNkvJdNuzCoPzdK7ezzNu3A++a5jxppssWLi3+YDsKzo2b5JFKTRp6PO0wDOfmz611MMQMW7Bz2rznwreHaCSWfNejadKZAu4Zz0rjxNPkkdkZ8yGodkw7+1dLo9wZEWNj06Gsa5tgsYc4Bp+l3KRSqS6gZ71y3Rb1R0l7GTBtzk4PeuSuYlDMrHFdHc6hCVCxDdx1rCuwSwZu9RJ2Y4q6PP/ABLZgOW24yO4riplKuy9816Z4kgDxM3XFedaohSXK8Zr38BU5oWPPrxsyiTgVGrYah25xURPzcV6iRytm7pLjzRXqHh6cQS2l0eRFIjkewIz/I15Hpj4lX616loQ83TCPVf8/wA68nMFazOqhroYHxHtPIkk9Irl0/A//qrmz+88NZ/iikz+td78S4fMgvpAO8c35j/7KuG0gCbR76I9gWx/wEn+lbYaV6SfZinH3il8XojtsbvjbPB1H1B/9mryyvWviGv2rwDpF31aP92xx7Y/9lryWvWwb/d27HBX+I+h/hwmPhZYp3kvU/8AQnP9K9E+HcTN4y8Wz9jOQP8Avv8A+tXAfDwj/hW2j+n2+LP/AI/XpPw0IPiDxP7XBH/jxr5bGv8Aiev6nr0tl6GH+0HLttwv/TKMfmW/wr5r1A/um9x/U19D/tDyEMoB4McX83r51vjmJs+n9TXq5Sv3KObEmQ3JpM0E0hr3DgF71ZsADdx+gOaq5q1p7BZmJ/umlLYZ1/hOMby5JH4ZFej6IC5wM57n1FcH4TMIiHDbzXp3heFJtp53Z496+cx8veZ6tBWgdFpjPHFls+lVr+72MRwfWtttPP2cNGADjkCuP1ZJVmZsECvMjaTNkiYy5J2tkmkjl2bsHIz3rKWZh7d6Q36oGEhxnjNaqApE9/djDdwPesG7dHiJkUbj0FVb3UdjhCR8x4wKp3ErshkLZHX3rupUrHNNl1LVZ0UCPAxyaz7i0h061nndtoTkmtbSpZCNuG2kVy3j6W4SBo+kDfeA61vSTlPkuZSdlc57QJftWsyXEv8AE3T+VddfKFA2j5W5AHQVxPhw5uYyARzziu1MqC58uQ5AGB6+1deIVp6E0n7pzfim1ZrZXCksOSRXKrM8YKhsGvR9UgE8e3Hy45/OvPdWt/s92yfiDXRhZ8y5WZV017yLWjSmOXLMQGrQ1WOK5aKS2P70fex3NYlqpZcqTkVdsLkW9yvmglcjIFaTj73MhReiTOt8KobbclyNpYblz1rsdLvo5AXOcdAcda5LWpRc+HftUI2NEwb5fSpvB2pSTzLDLGCCcj2rzKsHUi5m6fK7HqNllgCCADwSak1CGN4WjlIxjhgaptPHDb+pxwBXOarq8zHYSR2GPSvNhTc3oW3YrGe00qVl3AjOeDW3p/iYNtS1Vm464rlba0+0y5mHHOSeK6TSIbfjy04Wta8IW11ZtTbZvxz318A0nyrU8FuY5RvJ9quaPGWTqNuMAHtUVyfLuSvXmvKlvY7Iy6HTaXGjQgMAeOKZq0ARMgfTNN0GTCjcMj+VXNTTKFmwQexrOS0Ji3c4nWBvt2AUdK8x1wES49Ca9V1HIikUYH4V5Z4iz5z89zXq5Y9bHLiTCbrg0wnk0pPHvTO9e6jgZcsG2yivXfBo8ywX6kfyryCyPzg17J4DA+wAN13GvJzZ2p3OzCayHeOowdMvMgfNYwt+IVP8K848PB/sl6IwpYqBg/l/WvUvG6j+yrknGBp0f/oK15r4YT93O2AQcY/Oowsv3L9UXUXvL0IPEy+Z8I1IH+ruB/6E3+NeOV7RrhX/AIVBdKVBInyD6fOK8Xr3MHtL1Z5mI3R734BuMfDOxOTiO+jP6uK9Q+Gs2PE/imPjImLf+PmvE/Ad0T8OLiME/urhW+nzj/4qvU/h9ebPHusr2uIRIPfIDV89j4aVPV/mj1KDvy+hT/aF5igk/vRKPyP/ANlXzvdtmJsV9JfHiMT6DbSLyyhs/of/AGU1813P3SPrXoZQ70F6nPiviMw0nWlbrTa9w4RakiJDVFTkPzCkwPQvCjHygSBt6e9ejeG5SgRo2zz3rzLwswMH3jx1ArvtCk+QYbIBzj0r5zGx95nr0PgPVNKuy0LFx265qvqVtHIp2KDnr7VnaVKdqrndgfnVqabjjIPSvJktS0YV5pi/OccegrmdV0+YIxXIUA9K7mRwQVbGevNUbpFljcHAGOlXTqOLKex4zetJDIVfdtplvdCSWKME4zzitjxRZssxwufp2rnoAUkbJHTNfQUmpwucU00zsLEyKFIxxxkGs7xwiyaFK6tlhgjJqTSbkmMFzkngA1D4vLjQpwEw56Y7VjCLVVepMn7pyHhDcJSpAIYEHNdLcxxyTgoSGTqTzXK+HbpEiaNuHLDkHBrqLYLIHLDEh/j9K666am2TS+FEtjMJsQMoDEYJPWuL8WxY1icAH5eK7rSrBhcR5JY8/N3FcbrbLJrd9GeQZW59OaWHaVR27BVV42Zi2zlCFU/WrbELGgOM559akSzjJwxG89DQ2nyG58suAOu412OSbMUmkdC5EnhZ44WILY5+hzVLw7fCzkLBgWJzTrbTr9Lc+XIpgUE/OMVhwSrDeEqcgHpWEYKSlFO5pJ2aZ69Z3guYY2ViGIB5Oai1OF3ZDz83pXI6LfOuQr9+Bnmuh0++NzMFY/MOOtefKi6bujS6Zt6fEVUfIGIHFaNmTbkrIFG7kD0qpaSLbkOW355qsJbibVNzIRH0HPUVxzXNc3gz0Lw/5cqHC59T0qlrWYrw4PFWNBOyNQoOMUzX9hnUgZOOa81r3jqpvUveHJSJMZ610t7GrQkvzn34rkvDwLTYBx6V1s5MdrgYzSlsN/Ecbqse3zACfavKfEwxNJu9a9T1KQgS5P4Zry3xTkzSfWu/LPiObE7HMMeRim5560NweabkZr6FHnMuWTZcD3r1/wAEBjbxLztLc/mP8a8f08Fpxn1r2XwihjsQ+OFRj+OAf6V5GbP3Ejtwauy346P/ABKr7kfLZxL/AOOp/jXCaFFs0+NgCCwz+Rz/AErs/iPMIrLUUHXekP5YH/stcdZSCPRgx7Rsf0asKF/ZW8/0NZfF8jM107PhHPnq8wA/77P+FeN16/41b7P8MLCEnBmlDY9vnP8AUV5BX0GC+GT82eVifiXoelfDibzPCmt2w5IBf8gD/wCy16N4XvDB410Kfd8l7aRqfc7dn8xXlPwjuVTX5LSUgRXMRQ5/L+RNddbXzWyaDOxxJYXT27ewDBh/M152Mpc05x7/AKr/ADR2YefuxZ6p8VIhceFQ/Uh9p+hBH/s1fL0/Vx3r6u8SImoaBeRr8wePemPXqP1xXyxqsJhvplxgBjj6dqzyaV4OI8WtUzGcfMaaRxUkvDmoweK99HAJTh1pKUdRTA7HwpM23aG2jPT1rutEZ/PO7of1rzvwzKsN1tbnnivRtGnijuVYgndgHntXhY5Wk9D1MM7xPQdH3qEJOcjtWjeRZUsSBjp6VQ0q5RYQUAJ7DrS3kk07NkhQa8SWrNluVrm4SNzvbnsaom9Vdw3ZHuKdcW+c5+maqNart5PFVFIpnK+KHEpYBeCOPWuMaFzMNwJIGRgV6RqFijMRnPYH0rn309kmU7ByepNethqqjGxy1I3KlgMxxxgDPXA6/Sruo2rTWhccgcYPrVhLQR7XQ4Ynqabql3b2Vsyu2CR61XM3L3TNrueV6pA9lfs68KWyQOxrqtFv454YwAfMY8965zxBcPe3LGFPlJwMdwKm8MTCOYBhg16dSPNTu9zng7Ssj0hP9EiLSt8oUtnPpXl08zPdSz4HzEnP613mvXIj0Y5PBTaCO2a87gBmk2AHiufBwsnJmtV3si6E81kZTh8ZNbmmWDTlSRll/Wq+kWRwXccDmp9T1WK1TyLPBuG4yP4a0nJyfLESSSux/ia8jzDp1uWUnmQL39BVePw4tzCNg2OB1zWfY27m83T581jkk13diQ8QCjLDHHes5ydGKUQS53dnGNYX1jJtKZUcVe0+92TZIaORfvD1ruAUMgimVQp4JI7VLL4fsrhCIlw3tWEsUn8aKUWtjG03U1cfOxPPeuh065hmck5GCMZ71zOoeGbyxy1mfMT06EUuly3VsGS8jYjtkYxXPVhCcbwZ0U5a2Z6rpksaoCpJB4qDV5PMuflPasbSdRTyF55x0NXBc75N2ea8iUWmdkEb3h1SJM966mcqLYs2QcflXOaGVUAmtXUbnFuABgdeazlsTvI5fU3wsh4PfNeW+JZMySH1NekanJ+4kIJNeW+IpCZGz3J616WWR945sS9DCf146Uw98UrHimFs176POZo6UC1ygr2rwcwke0tWICyuoJ9s/wCBrxLTmKzBh2r0Pw1rjqWZU/eJGQPQZG0fqRXl5jSdRK3Q68NNRLHxAvfPXOcCe6aT8B/+1XOalP8AZ9H8tevlY/Mgf41L4ouvPu7WIYARckD1Y5/lisrU5RcqiA/62dYx9B/+ujD0rRin6mk5bsi+Kk+zR9GsxwEh3Ef8BUfzzXltd58T7rz9XWLIxDAFx9ST/IiuDr2MJG1JHm4h3ma/hS6+x+ILOXdtG/aT9eK9GvE3nXISfn3JfRf+zY/76/SvI1YqwYcEHIr1KK9WdtEvXwEnQ2kx9mH/ANc/lWOLh7ykv6tqaYeWjR6/4R1Iah4Zs5HIYmPy2+o4/wAK8H8b2RtNclRwQqsVzjqAeP0xXonwxv3ga90mckSW7kgenODWL8X7PbdLcqOJEzn3H/1iPyrycGvYYqVPo/6R2Vvfp3PLLtAHJXlfWqtWHG4YFV2yDg9q+iiecw70v0ptGaoRtaTKBPC7dOhr0CzuEzG2Wx+deX2kmBjPQ5rttJkWS3Uk4YDgjtXm4ynfU7sLPoeo6JeBtiZOOua6KNvNYV57oVyFRACdx5967jTWZo9zDJHSvBqwszse43UFZUORjANZKSM7bGyPU1vzxCUgjp3qubQedv24B9PSsVKxRQntdyhmIAHJrJuDBbvvk27Qf4q2NW1G2s4yGwz4+7Xl+u6lNe3BRSwUk4A4GK7MNTlU8kY1NC5rviNDO8dptBHJbPArk7iWfUJFf5mHU5+varkGn72xNgk9qtwRiCNx0IPHHSvWgoU1aO5yuLe4/R9IiCjzEHONxNc5qEB0/WZlRWWEsAMdD9DXX2shST5myCw4x1q3cWUF848yMMCeB6H1qY1nCTctmDjfY57XSbnSYShIK8496ydDhSCN5p8YzyD3/wA5rQ8T2lzpTgrJmFuiMc4rAtZXvphE/ES8kD1ropRvT0ehMpe95mncXFxcJKLQNFCOCQPm/wDrVWsoEdlJ4YHBJ7+9dppelLJbMoKtxjI7muY1W1fT7kjbwjbvwzU06qk3FDlG2rN2K1SWNWVQWUcGtnTrctEdn3j3XqK53Q74s20t09e9dTpSl5Q0IKoedue9cta8dGXo9UW7u1KwBzy4HbvVLSNVkgl2SqSc4yTXRCzJTbJkF881xt1bPb6o0bZAzkGuam1NOLLSPRLGSO5wT9w98ZrQGm2lzkNGpPpiuW0C5KqEzlQeMdK65GCAN68151W8ZaHUo2Kd54dSPD24Cg9sdKzZLGeFvlRmXvgV0H24sMZP5Vq6RGsj5kUMvesbvqaqbiYemT7ECkHPv2q/fTkxjnr05rR1aytUBaNVViO1c5cSbflz8o9qiWoKz1MbW5dsDDGPxrzLXZgZwo6jrXc+JLwElQcpjJrzK8mMszuTyTXu5dStG7PPxMtbEbnP0po+90ppbOeaVDlq9U5DqPCtitzIdwBXGeRXfR6NDpegy7Buu7yZY4z3VV5P6sn5VzPgSEbS7YHHI9h/n9K6rxbfrBn7Oc/Yodu7/pq3XH0LAf8AAa8PE1Jyrckdj0qMI8ibOC1AiXWJ9hyoYqv0HGf0qpZwtJqdtH2iQyn6k5H8xU9qgYSsx5OEBPqetMhuUgsNT1ZwRuykI+gwP1K/lXfHTRehlLa5w/iG5N5qV5PnIZzj6dB+lYdXJCQjZ7iqdevBWVjzKju7hXYeGbj7ZoN7YtkyRDzYsdQRz/jXH1qeHb1rHVYXB+VjtYHpiorR5o6BSlyyO40zVXtNcsNWP+ru0CyH/aHyt/IH8a7zxxbjUNAlaNfMMYEigdSPb8C36V5hdwkte2EP3V/0u2Ht/Eo/D/0Gu/8ABWrDVNDCSP8AvI/kbPJx614uKhyuNaPT+l/kehSle8WeNXMZjldfQ1VYHkmuo8aaa1hqUgCbUydp7Fe35cj8K5hxXs0pqcVJHHOPK2iOilpDWpA+FgsgJ6dDXT6Bd7JfLdsDoK5WtKxlOUdT8y8Gsa0OeNjSlPllc9P0mY+dknr0J713+jStKyEEFf6V5dpM3nRK6nhR1NejeFZlDA54xxmvnMTHlPWT5lc6sQL5bOThRz9a5rXtXEGUiwPTNamtaovkiOMEt7c1xU9pLcykvnjkVyU4Ju8hoy7nzLmTc+4gnk5p0NhFuJKfPjitf7LtUAjp6iolBV8gZyccdq61U6ITRizWoXftUA1G+nM1ozbcEDNdJ9lSQsxAOBzirAsi9k/GFxjPpVrEWMZRPLXvHS8CryynGD2rodMu/ssXmO+7PIrB1C2MV/KyjGW+8e9QXd0w8qPkfjXpygqiSRgvd3Oh8SqmqaRKxGSDkbTyK5jw5ZN5jF0wM8DvWpbXu+2ktyOScfWtrToYUsV+XLA/QmoUnSg4jsm7mrpyCIMy8Y4IrL8cafuhjuUQkgc1p2VwBJsZcfNn61sXcS3lpJCwBHY1xKbpzUhv3keQ6dkTkcgdR7V3GgzujoZGyT3FcjfwHTtRkVhjBAxXWaJGGQHkZrsxLTjcdKJ6FbPvRAwzkVS13w+skXnx/M+M57ik0hpfNAb5kwMV1tqBJD5bjcpPpnFeFKbpyujpUTzHTGa2cISRgk8108N4JYlGR1FVfEmnCC6LRrx32iq9gSjYIyDVTan7x0RV1c37VDLLgDC11FgBa4LenJNY+kRr5akkZxVzUL1BHw3GOtYMzerGaxeAqRnknqK5i+u1hgctjHX61Jdzli0jn5R71w/ibWhlokf5Qe1a4eg6srE1JqETP12+jMEp3/M5wqf1rkXbPPFS3Vw00m5jnsBVVj+VfTUqahGx5U58zHA81NbjLj60ljCbidUH41IBskYehxVt9CUup12hXawFAvpuIHfHQficfnVvXLki0SNjwT5jerHt/U/jWRoafxMccbmJ7D/P64qDWLsvMSfrj+QrgdJOr6HWptRHSzhbOXaeUXYuO7t/9bNZ3i6YWei2Omq2ZPvyD88/qT+VToR5tvEcYi/eyE93Pb+QrldfvPtupyyqxaPO1Ce4Hf8AHrXXRp3kvLUynU0ZnyH92fpVWp3PyGoK70ccwpQcHI60lFMg62G9kuNMtr2Pm6s2+bjkr3/z7mtDQb9NF19Cj5sbob1x/dPb6g8Vy3h+++xXw38xSDYwPTmtiW08tpNPILsv7+1cdWHdR/nqK4qlNawez/r8DrhNtKSO78caet7py3EWCUBJPXcpH/1gfw968nljMbsjdQe1el+DNZF/YNY3DYkjGFDdSK5fxZpDW127wp8mcjaOMen4fy+lYYSTpSdGZrWjzrnicr3xSGnMKTk16ZyDaltZfKkHoetRGkNG4HXaJfeW4Rz+7PQV3enam0QyjgAdO/NeRWU5BAzyOldTpWpeaVR2xXmYrDc2p3Yet0Z6naXvnBWc5z3rQjhDEntXC2N40RRf4fQ11WnX5dV6BQeea8apScdjsZfuo/3YLAZ7YrOSIhvm4zzWzPiUL5eMDt60+O2XncBv+lYp2Hco6XbDzCT930rYvLdIdPZXOFIzirelWYRtzjjGelZ3iW9Rj5KHis+ZykJo891uyTLMi5zkiuWlsXd/O2kgc5xXbasQYyN3J4xVO0tfkVWHB7etevSrOMTJ07s5TbtVi3ynOSa2rOZHt8MSPLGR71ujQYpV24+U9sVSuvD/AJKuYdwI4wRxVPEQnoRyNGVHqh89gvQAY9c13XhxfOiWRzlnAByK87s7M/bzGy4Ga9F0KF/KjRAeBissU4paDjHTU5f4jaMICt6FHJAbHQVW8KSmRFDHIJwa9H8VaZ9r8NzBlO5RnJrzHwyxhkK475xU0qvtKDT3RrCFpHpWnoI0DdhWnHqKxk+XnJ9KwLadmiABGD1rQsrck5xx0rzpK+5rbuaiWy6gxEmMn1rKvtIewuAcZQnI9q6LTiIoQSeQeQag1y6V1ycY7gVN7BGTuZ1vcGJAynAI5FV7q583Kg8Dr6VQuLk5IXgH9KxtV1NbWJgG+bHXNOFKVR2Q5SUdRviHVhawuinqD0rzW/uzPKzZ4qfV9Qku52yxOTVDyztyTX0WFw6ox13PLrVHUehGWpmaaxG6kBzxmuyxzmpp7eRBJLkBvuiktFM83IzzVMOWCoOlbOmRrEhkcDC8nJ6+341lP3U2ax96yNSRlt7UJkFiNzEdAP8AP8hWG8u6dpJBlI/nI9T2FTahctt+YkyOcnH8qqzgvIsJcMq/PKc9T6VFONtypO+w29uvsukySMcz3ZIHsO9cqT+VWdQnM87fNuVchaqZrspw5UYSlcRuhqKpD0NR1qZSCiiigkK6a2un1Oyj2kjULXmNhxkVzNWbC6ezuo54+qnOPWonHmXmXCXK/I2ftbWl3DqdoSodv3qD+F+4+h6iu6aSHXdKWaH/AFmM57g/5/rXGXbRHdeQjdZ3fy3Cf3D6im6LqMmh6j5bPvtn5Vh0IPQiuKrS9orx3X9WOuE+V2exn6rZta3DDaQhP5H0qifWvQ9csItQtvOgG4MP4T7/AOcVwd3btbzNG4+h9RW9Ct7SPmZ1YcruiuRTDTzTSK6DEQHByOtXLW4KsGBwRVPFKpwcik1cE2mdpY6ossaqCd4wM10+lXxDKOcda8wtLja4IbDjtXWaRqKtEFc/OP0rzcRh7LQ9ChX5tGep6Te7gG5wDiur01I7hk2glj615Lp+plJjg/LXo/hzU4o4Q5PO3P0rxa9JxOrfY2PEd0NLsFjJAlfgBa4uISzS7n5Gcml1fUGvdVd5GLAcDnpWjYBJUznAxWSjyIpbHPaxakYZcUWMByoI+deBW1e26uiqvOTimWsPlvhRzmtef3bAXLeNSny/eHbFXGska2O4ck81BGCkoAB461euJCls5zjiueV+gHn09mINRk2joeorsNAHyJkDPUmsOWPfOW7mtzTYiFAHA6da2qS5lqPodJeL5+mzRqM5Xp614vZwGHVpYyuMMeDXt2jwu2A/I6Zrh/HeifYNZjuYlGxxk81OHny3j3CL1G6VCJAOcc10EEiwqynj8K5yxm8pc8YP86nuL9toXqw4qZavQuUbs1bjUPL3Ju+7+tZV3cNMGLNhQM4rKnvFVGaQjI5xmuX1jxEFJ8ojPStaWGlUehnOpGCNvVtYht4WG7kelcFqmqSXch+Y7apXl491IWc9+gqqz9hXt4fCRpLzPOq1nMlDbTnPJ706STCEnvVcNmmu+76V12Mb2QhP505eOTUY681Ig3NgdKpkIt2URZt2MjPT1rT81OT/AMs4+pz95v8AAVnB/KURjIdv/HR61FcThwEVsRJ1PtWLXMzVe6rEsl1gmdvm7Rj39aoahcGG28nOZXO5jTDKATO/CLwi1mzytNIXbkmtoQIlIbmm0oPPNDEFzgbR6ZrczEbI61HUh7io6CGFFFFAgooooA0NKvvszNFKN1vLw6npWibZDGbeeULbn5reZucN/dPsa56tTTruNoWtbwExt9w/3TWU49Uawl0Zr+HtYewm+x3ynyycfP2/+tWnrmnJcKXTmNvmVgM49/8A61czcxs7LBcN++A/dS54ZfQ1o6JrT2/+h32dgOAT/Ca5503f2kNzeMr+5IxbmB4JCkgwf0I9RUBGK6/UtPjlQkAkdVKjJB9v8K5m7tnt3CyDg8qw6MPat6dVTM5wcSqRSEU/HFJg1qQNHr3q3b3DKcZwfWquKBSauC0Os0zUcDDEZ9Sa6ux1doIsI4IIwTmvLo5nTHNaNpqMicZyueRXFWwqkddLEW0Z6HDqJL7s9810Vlqix233s47g15nb6ojgA8GtH7d+6KRNwTniuCpheh1qqpHotvfLJgk/MDV+2mBOAQTjArz621N0x8ynjBq/aaqySBieB6fSuWVBlXTO/DhnEmcEDkVZu7hGtVAA5wCPWuIXW90mQc9M1LJrGYwSx25GMVg6MikjfjhTzxsxita18tGTOOece9cVbayQpOec/jU39sO7sUz8tJ05BY786rFAw+6B7fyrA8VanFewqnVlGOtcnLqkpeTL/Kap3OoxwtukfI9aI4eVwTUdTSWcRjB6fzqle6rFbKCxBYH161zWq+IFClYjz2rl7zUJbhyXYn2r0KOActZGNXFpaI2tZ115ncRn5fUGsB5WdssSaiZs9abu7V6tOlGCtE4Jzcndkue4700nJppbGKUEKCasm4rHAwOpqPJ4ozzRnnA61RNxwIzjqTU6EQpk8seg9ajwsQ3NyT0FQvIQdz8segpWuNaE7S7Qcnc7dears/mE84QdT61AzEkgck9TUUsoxsX7veqUQbC6n81gF4RelV80ZoPOK0SsZt3FopBR1NMQUynnpTKBM//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Aspergillus fumigatus growing on Sabouraud's agar.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aspergillus fumigatus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 289px; height: 208px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lactophenol-blue wet mount of Aspergillus fumigatus growing on Sabouraud's agar (x400). Note the characteristic \"fruiting bodies\" bearing strands of conidia or spores.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_20_21834=[""].join("\n");
var outline_f21_20_21834=null;
var title_f21_20_21835="Relaxation breathing PI";
var content_f21_20_21835=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F69706&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F69706&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Relaxation breathing exercises",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        This exercise can be used to help a child or adolescent who has chronic or recurrent pain. The exercise should be done for 10 minutes at least twice every day, and can be used at other times when pain is bothersome.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        The parent can read the following instructions to their child, or an older child or adolescent may read the instructions on their own.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        1. Lie down or sit in a comfortable chair. Remove any items that are uncomfortable, including tight clothing, glasses, or jewelry.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2. Close your eyes and try to relax every muscle in your body. Pay special attention to the muscles of the face, mouth, tongue, and jaw.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        3. Place one hand on the belly; this hand should move when taking a deep breath.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        4. Follow your breathing as you breathe in deeply and slowly through your nose into your belly. You should feel your belly rise and fall.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        5. Breathe out through your mouth, keeping your mouth, tongue, and jaw relaxed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        6. Focus on the sound and feeling of long, slow, deep breaths.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        7. Continue breathing in and out slowly for at least 10 minutes.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_20_21835=[""].join("\n");
var outline_f21_20_21835=null;
var title_f21_20_21836="Sources of quinine";
var content_f21_20_21836=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F60296&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F60296&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Commercially available sources of quinine",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tr>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Available forms of quinine:",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Quinine sulfate tablets (Formula Q&reg;)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Quinine-containing beverages (eg, quinine water, tonic water, bitter lemon, gin and tonic)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Herbal preparations containing quinine or bark from the Cinchona tree*",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Common names for quinine or quinine-containing herbal preparations:",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Calisaya bark",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          China bark",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Cinchona",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Cinchona bark",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Cinchona officinalis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Cinchonae cortex",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Fever tree (bark)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Jesuit's bark",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Kinakina",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Peruvian bark",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Red cinchona",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Quina",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Quina-quina",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Quinine bark",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Yellow cinchona",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    In 1995, the Food and Drug Administration banned the sale of all quinine-containing over-the-counter preparations because of lack of data to support its efficacy for the treatment of leg cramps. Quinine is, however, available by prescription. All of the commercially available forms listed above contain sufficient amounts of quinine to cause thrombocytopenia with a single \"serving.\" Although thrombocytopenia has been reported following the drinking of some of the listed beverages but not with any of the herbal preparations, we think that these herbal preparations are still possible sources for quinine-induced thrombocytopenia.",
"    <div class=\"footnotes\">",
"     * These preparations are available at several retail outlets in the United States; many are sold over the Internet by a large number of vendors.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Kojouri, K, et al. J Okla State Med Assoc 2000; 93:519.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_20_21836=[""].join("\n");
var outline_f21_20_21836=null;
var title_f21_20_21837="Pathogens cystitis in children";
var content_f21_20_21837=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F54955&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F54955&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Urinary tract pathogens in acute cystitis in children and adolescents",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Bacteria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Gram-negative bacilli",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            <em>",
"             Escherichia coli",
"            </em>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            <em>",
"             Pseudomonas aeruginosa",
"            </em>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            <em>",
"             Klebsiella",
"            </em>",
"            spp.",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            <em>",
"             Enterobacter cloacae",
"            </em>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            <em>",
"             Enterobacter aerogenes",
"            </em>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            <em>",
"             Morganella morganii",
"            </em>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            <em>",
"             Proteus mirabilis",
"            </em>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            <em>",
"             Providencia stuartii",
"            </em>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            <em>",
"             Serratia",
"            </em>",
"            spp.",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Gram-negative cocci",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            <em>",
"             Neisseria gonorrhoeae",
"            </em>",
"            *",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Gram-positive cocci",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            <em>",
"             Enterococcus",
"            </em>",
"            spp.",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            <em>",
"             Streptococcus",
"            </em>",
"            group B",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            <em>",
"             Streptococcus",
"            </em>",
"            group D",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            <em>",
"             Staphylococcus aureus",
"            </em>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            <em>",
"             Staphylococcus epidermidis",
"            </em>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            <em>",
"             Staphylococcus saprophyticus",
"            </em>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Other bacterial pathogens",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            <em>",
"             Chlamydia trachomatis",
"            </em>",
"            *",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Fungi",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            <em>",
"             Candida",
"            </em>",
"            spp.",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            <em>",
"             Trichosporon",
"            </em>",
"            spp.",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            <em>",
"             Aspergillus",
"            </em>",
"            spp.",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            <em>",
"             Microsporidia",
"            </em>",
"            spp.",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Viruses",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Adenovirus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Polyomaviruses",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            BK virus",
"            <sup>",
"             &bull;",
"            </sup>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            JC virus",
"            <sup>",
"             &bull;",
"            </sup>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            SV 40 virus",
"            <sup>",
"             &bull;",
"            </sup>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Herpes simplex virus*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Parasites",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Schistosoma",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Associated with sexually transmitted disease.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Most often in immunocompromised hosts.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_20_21837=[""].join("\n");
var outline_f21_20_21837=null;
var title_f21_20_21838="Contents: Pleural disease";
var content_f21_20_21838=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?8/24/8590\">",
"       Pulmonary, Critical Care, and Sleep Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pleural disease",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pleural disease",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Mesothelioma",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/50/32552\">",
"           Clinical presentation, diagnosis, and staging of malignant pleural mesothelioma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/28/7622\">",
"           Epidemiology of malignant mesothelioma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/33/29204\">",
"           Pathology of malignant pleural mesothelioma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/41/28312\">",
"           Treatment approaches for localized malignant pleural mesothelioma and solitary fibrous tumor of the pleura",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/62/4072\">",
"           Diagnosis and management of pleural causes of unexpandable lung",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/41/31382\">",
"           Imaging of pleural plaques, thickening, and tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/52/32582\">",
"           Large volume thoracentesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/27/4534\">",
"           Measurement of pleural pressure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/12/1226\">",
"           Placement and management of thoracostomy tubes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/22/32103\">",
"           The pleura in lung transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/42/25254\">",
"           Thoracic endometriosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pleural effusion",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/24/36232\">",
"           Chemical pleurodesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/45/31448\">",
"           Clinical presentation, diagnosis and management of cholesterol effusions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/7/16505\">",
"           Diagnostic evaluation of a pleural effusion in adults: Initial testing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/36/2632\">",
"           Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/23/12663\">",
"           Diagnostic thoracentesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/20/37192\">",
"           Etiology, clinical presentation, and diagnosis of chylothorax",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/35/30263\">",
"           Hepatic hydrothorax",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/56/21384\">",
"           Imaging of pleural effusions in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/59/42933\">",
"           Indications for diagnostic thoracoscopy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/32/31241\">",
"           Management of chylothorax",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/6/13416\">",
"           Management of malignant pleural effusions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/29/37334\">",
"           Management of refractory nonmalignant pleural effusions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/53/36695\">",
"           Mechanisms of pleural liquid accumulation in disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/32/9735\">",
"           Mechanisms of pleural liquid turnover in the normal state",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/27/28089\">",
"           Parapneumonic effusion and empyema in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/21/16728\">",
"           Pleural effusions following cardiac surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/27/23993\">",
"           Pleural effusions in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/53/29527\">",
"           Pleural fluid eosinophilia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/57/30615\">",
"           Talc pleurodesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/50/26408\">",
"           Thoracic ultrasound: Indications, advantages, and technique",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/47/22261\">",
"           Tuberculous pleural effusions in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/35/12856\">",
"           Tuberculous pleural effusions in HIV-negative patients",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pneumothorax",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/28/35271\">",
"           Pneumothorax and air travel",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/12/20678\">",
"           Pneumothorax in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/3/10297\">",
"           Primary spontaneous pneumothorax in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/35/24121\">",
"           Secondary spontaneous pneumothorax in adults",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-04F65D0CB4-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f21_20_21838=[""].join("\n");
var outline_f21_20_21838=null;
var title_f21_20_21839="Mechanical triggering";
var content_f21_20_21839=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F63023&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F63023&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mechanical triggering with flexor tenosynovitis (trigger finger)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 369px; height: 275px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The hands are placed in the palms up position and the patient is asked to actively flex and extend the fingers. Alternatively, if active triggering is not present, the examiner places his fingers on the proximal interphalangeal (PIP) joint as the finger is actively flexed and extended, noting the presence of loss of smooth motion or a clicking sensation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_20_21839=[""].join("\n");
var outline_f21_20_21839=null;
